ROS Cancer Research Results

ROS, Reactive Oxygen Species: Click to Expand ⟱
Source: HalifaxProj (inhibit)
Type:
Reactive oxygen species (ROS) are highly reactive molecules that contain oxygen and can lead to oxidative stress in cells. They play a dual role in cancer biology, acting as both promoters and suppressors of cancer.
ROS can cause oxidative damage to DNA, leading to mutations that may contribute to cancer initiation and progression. So normally you want to inhibit ROS to prevent cell mutations.
However excessive ROS can induce apoptosis (programmed cell death) in cancer cells, potentially limiting tumor growth. Chemotherapy typically raises ROS.
-mitochondria is the main source of reactive oxygen species (ROS) (and the ETC is heavily related)
ROS Homeostasis in Cancer Cells and Its Potential as a Therapeutic Target

"Reactive oxygen species (ROS) are two electron reduction products of oxygen, including superoxide anion, hydrogen peroxide, hydroxyl radical, lipid peroxides, protein peroxides and peroxides formed in nucleic acids 1. They are maintained in a dynamic balance by a series of reduction-oxidation (redox) reactions in biological systems and act as signaling molecules to drive cellular regulatory pathways."
"During different stages of cancer formation, abnormal ROS levels play paradoxical roles in cell growth and death 8. A physiological concentration of ROS that maintained in equilibrium is necessary for normal cell survival. Ectopic ROS accumulation promotes cell proliferation and consequently induces malignant transformation of normal cells by initiating pathological conversion of physiological signaling networks. Excessive ROS levels lead to cell death by damaging cellular components, including proteins, lipid bilayers, and chromosomes. Therefore, both scavenging abnormally elevated ROS to prevent early neoplasia and facilitating ROS production to specifically kill cancer cells are promising anticancer therapeutic strategies, in spite of their contradictoriness and complexity."
"ROS are the collection of derivatives of molecular oxygen that occur in biology, which can be categorized into two types, free radicals and non-radical species. The non-radical species are hydrogen peroxide (H 2O 2 ), organic hydroperoxides (ROOH), singlet molecular oxygen ( 1 O 2 ), electronically excited carbonyl, ozone (O3 ), hypochlorous acid (HOCl, and hypobromous acid HOBr). Free radical species are super-oxide anion radical (O 2•−), hydroxyl radical (•OH), peroxyl radical (ROO•) and alkoxyl radical (RO•) [130]. Any imbalance of ROS can lead to adverse effects. H2 O 2 and O 2 •− are the main redox signalling agents. The cellular concentration of H2 O 2 is about 10−8 M, which is almost a thousand times more than that of O2 •−".
"Radicals are molecules with an odd number of electrons in the outer shell [393,394]. A pair of radicals can be formed by breaking a chemical bond or electron transfer between two molecules."

Recent investigations have documented that polyphenols with good antioxidant activity may exhibit pro-oxidant activity in the presence of copper ions, which can induce apoptosis in various cancer cell lines but not in normal cells. "We have shown that such cell growth inhibition by polyphenols in cancer cells is reversed by copper-specific sequestering agent neocuproine to a significant extent whereas iron and zinc chelators are relatively ineffective, thus confirming the role of endogenous copper in the cytotoxic action of polyphenols against cancer cells. Therefore, this mechanism of mobilization of endogenous copper." > Ions could be one of the important mechanisms for the cytotoxic action of plant polyphenols against cancer cells and is possibly a common mechanism for all plant polyphenols. In fact, similar results obtained with four different polyphenolic compounds in this study, namely apigenin, luteolin, EGCG, and resveratrol, strengthen this idea.
Interestingly, the normal breast epithelial MCF10A cells have earlier been shown to possess no detectable copper as opposed to breast cancer cells [24], which may explain their resistance to polyphenols apigenin- and luteolin-induced growth inhibition as observed here (Fig. 1). We have earlier proposed [25] that this preferential cytotoxicity of plant polyphenols toward cancer cells is explained by the observation made several years earlier, which showed that copper levels in cancer cells are significantly elevated in various malignancies. Thus, because of higher intracellular copper levels in cancer cells, it may be predicted that the cytotoxic concentrations of polyphenols required would be lower in these cells as compared to normal cells."

Majority of ROS are produced as a by-product of oxidative phosphorylation, high levels of ROS are detected in almost all cancers.
-It is well established that during ER stress, cytosolic calcium released from the ER is taken up by the mitochondrion to stimulate ROS overgeneration and the release of cytochrome c, both of which lead to apoptosis.

Note: Products that may raise ROS can be found using this database, by:
Filtering on the target of ROS, and selecting the Effect Direction of ↑

Targets to raise ROS (to kill cancer cells):
• NADPH oxidases (NOX): NOX enzymes are involved in the production of ROS.
    -Targeting NOX enzymes can increase ROS levels and induce cancer cell death.
    -eNOX2 inhibition leads to a high NADH/NAD⁺ ratio which can lead to increased ROS
• Mitochondrial complex I: Inhibiting can increase ROS production
• P53: Activating p53 can increase ROS levels(by inducing the expression of pro-oxidant genes)
• Nrf2 inhibition: regulates the expression of antioxidant genes. Inhibiting Nrf2 can increase ROS levels
• Glutathione (GSH): an antioxidant. Depleting GSH can increase ROS levels
• Catalase: Catalase converts H2O2 into H2O+O. Inhibiting catalase can increase ROS levels
• SOD1: converts superoxide into hydrogen peroxide. Inhibiting SOD1 can increase ROS levels
• PI3K/AKT pathway: regulates cell survival and metabolism. Inhibiting can increase ROS levels
• HIF-1α inhibition: regulates genes involved in metabolism and angiogenesis. Inhibiting HIF-1α can increase ROS
• Glycolysis: Inhibiting glycolysis can increase ROS levels • Fatty acid oxidation: Cancer cells often rely on fatty acid oxidation for energy production.
-Inhibiting fatty acid oxidation can increase ROS levels
• ER stress: Endoplasmic reticulum (ER) stress can increase ROS levels
• Autophagy: process by which cells recycle damaged organelles and proteins.
-Inhibiting autophagy can increase ROS levels and induce cancer cell death.
• KEAP1/Nrf2 pathway: regulates the expression of antioxidant genes.
    -Inhibiting KEAP1 or activating Nrf2 can increase ROS levels and induce cancer cell death.
• DJ-1: regulates the expression of antioxidant genes. Inhibiting DJ-1 can increase ROS levels
• PARK2: regulates the expression of antioxidant genes. Inhibiting PARK2 can increase ROS levels
• SIRT1 inhibition:regulates the expression of antioxidant genes. Inhibiting SIRT1 can increase ROS levels
• AMPK activation: regulates energy metabolism and can increase ROS levels when activated.
• mTOR inhibition: regulates cell growth and metabolism. Inhibiting mTOR can increase ROS levels
• HSP90 inhibition: regulates protein folding and can increase ROS levels when inhibited.
• Proteasome: degrades damaged proteins. Inhibiting the proteasome can increase ROS levels
• Lipid peroxidation: a process by which lipids are oxidized, leading to the production of ROS.
    -Increasing lipid peroxidation can increase ROS levels
• Ferroptosis: form of cell death that is regulated by iron and lipid peroxidation.
    -Increasing ferroptosis can increase ROS levels
• Mitochondrial permeability transition pore (mPTP): regulates mitochondrial permeability.
    -Opening the mPTP can increase ROS levels
• BCL-2 family proteins: regulate apoptosis and can increase ROS levels when inhibited.
• Caspase-independent cell death: a form of cell death that is regulated by ROS.
    -Increasing caspase-independent cell death can increase ROS levels
• DNA damage response: regulates the repair of DNA damage. Increasing DNA damage can increase ROS
• Epigenetic regulation: process by which gene expression is regulated.
    -Increasing epigenetic regulation can increase ROS levels

-PKM2, but not PKM1, can be inhibited by direct oxidation of cysteine 358 as an adaptive response to increased intracellular reactive oxygen species (ROS)

ProOxidant Strategy:(inhibit the Mevalonate Pathway (likely will also inhibit GPx)
-HydroxyCitrate (HCA) found as supplement online and typically used in a dose of about 1.5g/day or more
-Atorvastatin typically 40-80mg/day, -Dipyridamole typically 200mg 2x/day Combined effect research
-Lycopene typically 100mg/day range (note debatable as it mainly lowers NRF2)

Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy
ROS-Inducing Interventions in Cancer — Canonical + Mechanistic Reference
-generated from AI and Cancer database
ROS rating:  +++ strong | ++ moderate | + weak | ± mixed | 0 none
NRF2:        ↓ suppressed | ↑ activated | ± mixed | 0 none
Conditions:  [D] dose  [Fe] metal  [M] metabolic  [O₂] oxygen
             [L] light [F] formulation [T] tumor-type [C] combination

Item ROS↑ NRF2 Condition Mechanism Class Remarks
ROS">Piperlongumine +++ ↓ [D][T] ROS-dominant
ROS">Shikonin +++↓/±[D][T]ROS-dominant
ROS">Vitamin K3 (menadione) +++↓[D]ROS-dominant
ROS">Copper (ionic / nano) +++↓[Fe][F]ROS-dominant
ROS">Sodium Selenite +++↓[D]ROS-dominant
ROS">Juglone +++↓[D]ROS-dominant
ROS">Auranofin +++↓[D]ROS-dominant
ROS">Photodynamic Therapy (PDT) +++0[L][O₂]ROS-dominant
ROS">Radiotherapy / Radiation +++0[O₂]ROS-dominant
ROS">Doxorubicin +++↓[D]ROS-dominant
ROS">Cisplatin ++↓[D][T]ROS-dominant
ROS">Salinomycin ++↓[D][T]ROS-dominant
ROS">Artemisinin / DHA ++↓[Fe][T]ROS-dominant
ROS">Sulfasalazine ++↓[C][T]ROS-dominant
ROS">FMD / fasting ++↓[M][C][O₂]ROS-dominant
ROS">Vitamin C (pharmacologic) ++↓[Fe][D]ROS-dominant
ROS">Silver nanoparticles ++±[F][D]ROS-dominant
ROS">Gambogic acid ++↓[D][T]ROS-dominant
ROS">Parthenolide ++↓[D][T]ROS-dominant
ROS">Plumbagin ++↓[D]ROS-dominant
ROS">Allicin ++↓[D]ROS-dominant
ROS">Ashwagandha (Withaferin A) ++↓[D][T]ROS-dominant
ROS">Berberine ++↓[D][M]ROS-dominant
ROS">PEITC ++↓[D][C]ROS-dominant
ROS">Methionine restriction +↓[M][C][T]ROS-secondary
ROS">DCA +±[M][T]ROS-secondary
ROS">Capsaicin +±[D][T]ROS-secondary
ROS">Galloflavin +0[D]ROS-secondary
ROS">Piperine +±[D][F]ROS-secondary
ROS">Propyl gallate +↓[D]ROS-secondary
ROS">Scoulerine +?[D][T]ROS-secondary
ROS">Thymoquinone ±±[D][T]Dual redox
ROS">Emodin ±±[D][T]Dual redox
ROS">Alpha-lipoic acid (ALA) ±↑[D][M]NRF2-dominant
ROS">Curcumin ±↑/↓[D][F]NRF2-dominant
ROS">EGCG ±↑/↓[D][O₂]NRF2-dominant
ROS">Quercetin ±↑/↓[D][Fe]NRF2-dominant
ROS">Resveratrol ±↑[D][M]NRF2-dominant
ROS">Sulforaphane ±↑↑[D]NRF2-dominant
ROS">Lycopene 0↑—Antioxidant
ROS">Rosmarinic acid 0↑—Antioxidant
ROS">Citrate 00—Neutral


Scientific Papers found: Click to Expand⟱
4112- MF,    Novel protective effects of pulsed electromagnetic field ischemia/reperfusion injury rats
- in-vivo, Stroke, NA
*cardioP↑, *Bcl-2↑, *BAX↓, *ROS↓,
4113- MF,    ROS_levels_in_H2O2-treated_Glioblastoma_Cell_Line">Post-exposure Effects of PEMF on ROS levels in H2O2-treated Glioblastoma Cell Line
- in-vitro, Nor, U87MG
*ROS↓, *SOD2↑,
4116- MF,    Low‑frequency pulsed electromagnetic field promotes functional recovery, reduces inflammation and oxidative stress, and enhances HSP70 expression following spinal cord injury
- in-vivo, Nor, NA
*Inflam↓, *TNF-α↓, *IL1β↓, *iNOS↓, *ROS↓, *Catalase↑, *SOD↑, HSP70/HSPA5↑,
4118- MF,    Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease
- Review, AD, NA
*cognitive↑, *BDNF↑, *neuroP↑, *memory↑, *ROS↓, *antiOx↑, *Aβ↓, *eff↑,
3464- MF,    Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology
- Review, Var, NA
AntiTum↑, TumCG↓, TumCCA↑, Apoptosis↑, TumAuto↑, Diff↑, angioG↓, TumMeta↓, EPR↑, ChemoSen↑, ROS↑, DNAdam↑, P53↑, Akt↓, MAPK↑, Casp9↑, VEGFR2/KDR/Flk1↓, P-gp/ABCB1↓,
3477- MF,    Electromagnetic fields regulate calcium-mediated cell fate of stem cells: osteogenesis, chondrogenesis and apoptosis
- Review, Var, NA
*Ca+2↑, *VEGF↑, *angioG↑, Ca+2↑, ROS↑, Necroptosis↑, TumCCA↑, Apoptosis↑, *ATP↑, *FAK↑, *Wnt↑, *β-catenin/ZEB1↑, *ROS↑, p38↑, MAPK↑, β-catenin/ZEB1↓, CSCs↓, TumCP↓, ROS↑, RadioS↑, Ca+2↑, eff↓, NO↑,
3462- MF,    The Effect of a Static Magnetic Field on microRNA in Relation to the Regulation of the Nrf2 Signaling Pathway in a Fibroblast Cell Line That Had Been Treated with Fluoride Ions
- in-vitro, Nor, NA
*NRF2↑, *Keap1↓, *SOD↑, *GPx↑, *ROS↓, *MDA↓, *SOD1↑, *SOD2↑, *GSR↑,
3470- MF,    Pulsed electromagnetic fields inhibit IL-37 to alleviate CD8+ T cell dysfunction and suppress cervical cancer progression
- in-vitro, Cerv, HeLa
TNF-α↑, IL6↑, ROS↑, Apoptosis↑, TumCP↓, TumCMig↓, TumCI↓,
3465- MF,    Magnetic fields and angiogenesis
- Review, Var, NA
angioG↓, *angioG↑, selectivity↑, Ca+2↝, ROS↝,
3466- MF,    The effect of magnetic fields on tumor occurrence and progression: Recent advances
- Review, Var, NA
angioG↓, ROS↝, EGFR↝, TumCG↓,
3500- MF,    Moderate Static Magnet Fields Suppress Ovarian Cancer Metastasis via ROS-Mediated Oxidative Stress
- in-vitro, Ovarian, SKOV3
ROS↑, CSCs↓, CD44↓, SOX2↓, cMyc↓, TumMeta↓, TumCI↓, TumCMig↓, CD133↓, Nanog↓,
3468- MF,    An integrative review of pulsed electromagnetic field therapy (PEMF) and wound healing
- Review, Nor, NA
*other↑, *necrosis↓, *IL6↑, *TGF-β↑, *iNOS↑, *MMP2↑, *MCP1/CCL2↑, *HO-1↑, *Inflam↓, *IL1β↓, *IL6↓, *TNF-α↓, *BioAv↑, eff⇅, DNAdam↑, Apoptosis↑, ROS↑, TumCP↓, *ROS↓, *FGF↑,
3469- MF,    Pulsed Electromagnetic Fields (PEMF)—Physiological Response and Its Potential in Trauma Treatment
- Review, Nor, NA
*eff↑, *eff↝, *other↑, Ca+2↑, ROS↑, HSP70/HSPA5↑, *NOTCH↑, *HEY1↑, *p38↑, *MAPK↑,
3486- MF,    Pulsed electromagnetic field potentiates etoposide-induced MCF-7 cell death
- in-vitro, BC, MCF-10AT
ChemoSen↑, tumCV↓, cl‑PARP↑, Casp7↑, Casp9↑, survivin↓, BAX↑, DNAdam↑, ROS↑, eff↓,
3485- MF,    Cytoprotective effects of low-frequency pulsed electromagnetic field against oxidative stress in glioblastoma cells
- in-vitro, GBM, U87MG
*antiOx↑, *ROS↓, *cytoP↑,
3484- MF,    Extremely low frequency pulsed electromagnetic fields cause antioxidative defense mechanisms in human osteoblasts via induction of •O2 − and H2O2
- in-vitro, Nor, NA
*GPx↑, *SOD2↑, *Catalase↑, *GSR↑, *ROS↓,
3480- MF,    Cellular and Molecular Effects of Magnetic Fields
- Review, Nor, NA
ROS↑, *Ca+2↑, *Inflam↓, *Akt↓, *mTOR↓, selectivity↑, *memory↑, *MMPs↑, *VEGF↑, *FGF↑, *PDGF↑, *TNF-α↑, *HGF/c-Met↑, *IL1↑,
7389- MF,    Modulation of Hydrogen Peroxide Production in Cellular Systems by Low Level Magnetic Fields
- in-vitro, Var, HT1080 - in-vitro, PC, AsPC-1
H2O2↑, ROS⇅,
7390- MF,    A 60-Hz sinusoidal magnetic field induces apoptosis of prostate cancer cells through reactive oxygen species
- in-vitro, Pca, DU145 - in-vitro, Pca, PC3 - in-vitro, Pca, LNCaP
TumCG↓, Apoptosis↑, TumCCA↑, cl‑Casp3↑, ROS↑, eff↓, Dose↝, Dose↝, H2O2↑,
7384- MF,    ROS-production-in-HepG2?redirectedFrom=fulltext">Reactive oxygen species (ROS) production in HepG2 cancer cell line through the application of localized alternating magnetic field
- in-vitro, Liver, HepG2
ROS↑, tumCV↓, mtDam↑, Dose↝, ER Stress↑,
496- MF,    Low-Frequency Magnetic Fields (LF-MFs) Inhibit Proliferation by Triggering Apoptosis and Altering Cell Cycle Distribution in Breast Cancer Cells
- in-vitro, BC, MCF7 - in-vitro, BC, ZR-75-1 - in-vitro, BC, T47D - in-vitro, BC, MDA-MB-231
ROS↑, PI3K↓, Akt↓, GSK‐3β↑, Apoptosis↑, cl‑PARP↑, cl‑Casp3↑, BAX↑, Bcl-2↓, CycB/CCNB1↓, TumCCA↑, p‑Akt↓, TumCP↓, selectivity↑, eff↓,
525- MF,    Pulsed electromagnetic fields regulate metabolic reprogramming and mitochondrial fission in endothelial cells for angiogenesis
- in-vitro, Nor, HUVECs
*angioG↑, *GPx1↑, *GPx4↑, *SOD↑, *PFKM↑, *PFKL↑, *PKM2↑, *PFKP↑, *HK2↑, *GLUT1↑, *GLUT4↑, *ROS↓, *MMP↝, *Glycolysis↑, *OXPHOS↓,
526- MF,    Inhibition of Cancer Cell Growth by Exposure to a Specific Time-Varying Electromagnetic Field Involves T-Type Calcium Channels
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vitro, Pca, HeLa - vitro+vivo, Melanoma, B16-BL6 - in-vitro, Nor, HEK293
TumCG↓, Ca+2↑, selectivity↑, *Ca+2∅, ROS↑, HSP70/HSPA5↑, AntiCan↑,
527- MF,    Effects of Fifty-Hertz Electromagnetic Fields on Granulocytic Differentiation of ATRA-Treated Acute Promyelocytic Leukemia NB4 Cells
- in-vitro, AML, APL NB4
ROS↑, other↑, p‑ERK↑, TumCP↓,
529- MF,    Low-frequency magnetic field therapy for glioblastoma: Current advances, mechanisms, challenges and future perspectives
- Review, GBM, NA
Ca+2↑, ROS↑, ChemoSen↑, QoL↑, OS↑,
532- MF,    A 50 Hz magnetic field influences the viability of breast cancer cells 96 h after exposure
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7 - in-vitro, Nor, MCF10
TumCP↓, MMP↓, ROS↑, eff↝, selectivity↑,
533- MF,    Effects of extremely low-frequency magnetic fields on human MDA-MB-231 breast cancer cells: proteomic characterization
- in-vitro, BC, MDA-MB-231 - in-vitro, Nor, MCF10
TumCD↑, necrosis↑, mt-ROS↑, other↑, *STAT3↓, STAT3↑,
537- MF,  immuno,    Integrating electromagnetic cancer stress with immunotherapy: a therapeutic paradigm
- Review, Var, NA
Apoptosis↑, ROS↑, TumAuto↑, Ca+2↑, ATP↓, eff↑, eff↑,
538- MF,    The extremely low frequency electromagnetic stimulation selective for cancer cells elicits growth arrest through a metabolic shift
- in-vitro, BC, MDA-MB-231 - in-vitro, Melanoma, MSTO-211H
TumCG↓, Ca+2↑, COX2/PTGS2↓, ATP↑, MMP↑, ROS↑, OXPHOS↑, mitResp↑,
491- MF,    Pre-exposure of neuroblastoma cell line to pulsed electromagnetic field prevents H2 O2 -induced ROS production by increasing MnSOD activity
- in-vitro, neuroblastoma, SH-SY5Y
*Dose∅, *ROS↓,
490- MF,    Extremely Low Frequency Magnetic Field (ELF-MF) Exposure Sensitizes SH-SY5Y Cells to the Pro-Parkinson's Disease Toxin MPP(.)
- in-vitro, Park, SH-SY5Y
ROS↑,
509- MF,    Is extremely low frequency pulsed electromagnetic fields applicable to gliomas? A literature review of the underlying mechanisms and application of extremely low frequency pulsed electromagnetic fields
- Review, GBM, NA
Ca+2↑, TumAuto↑, Apoptosis↑, angioG↓, ROS↑,
500- MF,    Anti-Oxidative and Immune Regulatory Responses of THP-1 and PBMC to Pulsed EMF Are Field-Strength Dependent
- in-vitro, AML, THP1
ROS↑, Prx6↑, DHCR24↑, IL10↑,
503- MF,    Effects of acute and chronic low frequency electromagnetic field exposure on PC12 cells during neuronal differentiation
- in-vitro, Nor, PC12
ROS↑, Ca+2↑,
507- MF,    Effects of extremely low frequency electromagnetic fields on the tumor cell inhibition and the possible mechanism
- in-vitro, Liver, HepG2 - in-vitro, Lung, A549 - in-vitro, Nor, GP-293
MMP↓, TumCG↓, ROS↑, *Ca+2↓, Ca+2↑, selectivity↑, i-pH↑,
508- MF,  doxoR,    Synergistic cytotoxic effects of an extremely low-frequency electromagnetic field with doxorubicin on MCF-7 cell line
- in-vitro, BC, MCF7
ROS↑, Apoptosis↑, TumCCA↑,
520- MF,    Exposure to a 50-Hz magnetic field induced mitochondrial permeability transition through the ROS/GSK-3β signaling pathway
- in-vitro, Nor, NA
*MPT↑, *Cyt‑c↑, *ROS↑, *p‑GSK‐3β↑, *eff↓, *MMP∅, *BAX↓, *Bcl-2∅,
521- MF,    Magnetic field effects in biology from the perspective of the radical pair mechanism
- Analysis, Nor, NA
*RPM↑, *ROS↝,
194- MF,    Electromagnetic Field as a Treatment for Cerebral Ischemic Stroke
- Review, Stroke, NA
*BAD↓, *BAX↓, *Casp3↓, *Bcl-xL↑, *p‑Akt↑, *MMP9↓, *p‑ERK↑, *HIF-1↓, *ROS↓, *VEGF↑, *Ca+2↓, *SOD↑, *IL2↑, *p38↑, *HSP70/HSPA5↑, *Apoptosis↓, *ROS↓, *NO↓,
587- MF,  VitC,    Effect of stationary magnetic field strengths of 150 and 200 mT on reactive oxygen species production in soybean
- in-vitro, Nor, NA
*ROS↑, *SOD↓, other↓,
4568- MF,    Extremely low-frequency pulses of faint magnetic field induce mitophagy to rejuvenate mitochondria
- Study, Var, NA
*ETC↓, *OCR↑, *MMP↑, *ROS⇅, *MMP⇅,
4571- MF,    Magnetic Fields and Reactive Oxygen Species
- Review, Var, NA
*ROS⇅, *ETC↓, Dose↝, Dose↝,
4354- MF,  doxoR,    Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach
- in-vivo, BC, MDA-MB-231 - in-vivo, BC, MCF7
selectivity↑, Apoptosis↑, TumCI↓, tumCV↓, TumVol↓, eff↓, ChemoSen↑, ROS↑, Ca+2↑, TumCMig↓,
4355- MF,    Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism
- in-vitro, Nor, C2C12
*mt-OCR↑, *mt-ROS↑, *ECAR↑, *Dose↝, *Ca+2↑, *ATP↑, *other↑, *eff↓, *eff↝,
4356- MF,    Pulsed electromagnetic fields synergize with graphene to enhance dental pulp stem cell-derived neurogenesis by selectively targeting TRPC1 channels
- in-vitro, Nor, NA
*Diff↑, *TRPC1↑, *ROS↑,
4567- MFrot,    Oncogenic pathways and the electron transport chain: a dangeROS liaison
- Review, Var, NA
ROS↑, ETC↓, other↝, Fenton↑, RNS↑,
4569- MFrot,    Case Report: A new noninvasive device-based treatment of a mesencephalic H3 K27M glioma
- Case Report, GBM, NA
Dose↝, Dose↑, Dose↑, OS↑, toxicity↓, ETC↓, ROS↑,
4566- MFrot,    On the mitochondrial aspect of reactive oxygen species action in external magnetic fields
- Study, Var, NA
ROS↑, ETC↓, selectivity↑,
9295- MFrot,    Rotating Magnetic Field Therapy Induces System-Level Neuroprotection in A53T α-Synuclein Transgenic Mice Through Coordinated Suppression of Cellular Stress Pathways
- in-vivo, Park, NA
*Dose?, *motorD↑, *Strength↑, *mTOR↓, *ROS↓,
9267- MFrot,    EXTH-12. Oncomagnetic Monotherapy Mediated Anti-Tumor Immune Response in Glioblastoma
- Review, GBM, NA
TumCP↓, tumCV↓, ROS↑, MMP↓, ATP↓, DNAdam↑, TumCCA↑, TumCG↓, OS↑, Imm↑, CD4+↑, CD8+↑,

Showing Research Papers: 2001 to 2050 of 3052
Prev Page 41 of 62 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 3052

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 2,   NA↑, 6,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 2,   antiOx↓, 15,   antiOx↑, 49,   antiOx⇅, 4,   ARE↓, 1,   ARE↑, 2,   ARE/EpRE↑, 1,   Catalase↓, 39,   Catalase↑, 29,   Catalase∅, 2,   Ceru↓, 1,   Copper↓, 1,   Copper↑, 1,   CoQ10↝, 1,   cystine↓, 1,   DJ-1↓, 1,   ENOX2↓, 1,   Fenton↑, 36,   frataxin↑, 1,   GCLC↑, 1,   GCLM↓, 1,   GCLM↑, 2,   GPx↓, 18,   GPx↑, 20,   GPx1↓, 4,   GPx1⇅, 1,   GPx1∅, 1,   GPx4↓, 72,   GPx4↑, 2,   GSH?, 1,   GSH↓, 232,   GSH↑, 26,   GSH⇅, 2,   GSH∅, 3,   i-GSH↓, 1,   i-GSH∅, 1,   mt-GSH↓, 1,   GSH/GSSG↓, 24,   GSR↓, 7,   GSR↑, 5,   GSS↑, 1,   GSSG↓, 1,   GSSG↑, 7,   ox-GSSG↑, 1,   GSTs↓, 5,   GSTs↑, 8,   GSTs↝, 1,   GSTs∅, 1,   H2O2?, 1,   H2O2↓, 5,   H2O2↑, 53,   i-H2O2↓, 1,   i-H2O2↑, 1,   mt-H2O2↑, 1,   HNE↑, 1,   HO-1↓, 33,   HO-1↑, 53,   HO-1⇅, 1,   HO-1↝, 1,   HO-2↓, 1,   HO-2↑, 1,   hyperG↓, 1,   Iron↓, 5,   Iron↑, 50,   Iron↝, 2,   Iron∅, 1,   i-Iron↓, 2,   i-Iron↑, 10,   c-Iron↑, 1,   Keap1↓, 5,   Keap1↑, 5,   Keap1↝, 2,   ox-Keap1↓, 1,   rd-Keap1↑, 1,   lipid-P↓, 19,   lipid-P↑, 98,   lipid-P↝, 1,   MDA?, 1,   MDA↓, 13,   MDA↑, 53,   i-MDA↑, 4,   MGO↑, 1,   Mich↑, 1,   MPO↓, 2,   NADH↓, 4,   mt-NADH↓, 1,   NADPH/NADP+↓, 2,   NFE2L2↑, 1,   NOX↓, 2,   NOX↑, 1,   NOX2↑, 1,   NOX4↓, 2,   NOX4↑, 1,   NQO1?, 1,   NQO1↓, 8,   NQO1↑, 11,   Nrf1↑, 1,   NRF2↓, 86,   NRF2↑, 89,   NRF2⇅, 2,   NRF2↝, 2,   NRF2∅, 3,   p‑NRF2↓, 1,   p‑NRF2↑, 2,   OSI↑, 1,   p66Shc↓, 1,   p66Shc↑, 1,   PAO↑, 1,   Prx↓, 5,   Prx↑, 1,   Prx3↑, 1,   Prx4↓, 1,   Prx4↑, 1,   Prx6↑, 2,   PrxI↓, 1,   PrxI∅, 1,   ox-PrxI↑, 1,   PrxII↓, 2,   PrxII↑, 1,   PrxII∅, 1,   PYCR1↓, 1,   RNS↓, 1,   RNS↑, 5,   ROS?, 11,   ROS↓, 171,   ROS↑, 1834,   ROS⇅, 44,   ROS↝, 15,   ROS∅, 13,   i-ROS?, 1,   i-ROS↓, 2,   i-ROS↑, 8,   m-ROS↑, 1,   mt-ROS↓, 3,   mt-ROS↑, 53,   RPM↑, 3,   SAM-e↝, 1,   selenoP↓, 1,   selenoP↑, 2,   SOD?, 1,   SOD↓, 51,   SOD↑, 33,   SOD∅, 1,   mt-SOD↑, 1,   SOD1↓, 5,   SOD1↑, 4,   SOD2↓, 16,   SOD2↑, 10,   ac‑SOD2↓, 1,   T-SOD↓, 1,   TAC↓, 5,   TAC↑, 3,   TBARS↑, 4,   Thiols↓, 10,   i-Thiols↓, 1,   TKT↓, 1,   TKT↝, 1,   TOS↑, 1,   Trx↓, 21,   Trx↑, 4,   Trx1↓, 8,   Trx1↑, 2,   ox-Trx1↑, 2,   Trx2↓, 3,   TrxR↓, 55,   TrxR↑, 3,   TrxR1?, 1,   TrxR1↓, 20,   TrxR1↑, 2,   mt-TrxR1↓, 1,   uricA↓, 1,   VitC↓, 1,   VitE↓, 1,   xCT/SLC7A11↓, 27,   xCT/SLC7A11↑, 2,   xCT/SLC7A11∅, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

ATOX1↝, 1,   Ferritin↓, 8,   Ferritin↑, 1,   FPN↝, 1,   FTH1↓, 7,   FTH1↑, 1,   FTL↑, 1,   IronCh↑, 8,   LIP↑, 1,   Mets↑, 1,   NCOA4↑, 4,   NCOA4↝, 1,   Tf↓, 2,   Tf↑, 2,   TfR1/CD71↓, 2,   TfR1/CD71↑, 1,   TfR1/CD71↝, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↓, 2,   ADP:ATP↑, 4,   BCR-ABL↓, 1,   CDC2↓, 11,   CDC25↓, 30,   CDC25↑, 2,   CDC25↝, 1,   compI↓, 15,   compI↑, 1,   compII↓, 4,   compII↑, 1,   compIII↓, 8,   compIII↑, 1,   compIV↓, 1,   compV↓, 1,   compV↓, 1,   EGF↓, 7,   ETC?, 1,   ETC↓, 26,   ETC↝, 2,   FIS1↓, 1,   HSP60/HSPD1↓, 1,   HSP60/HSPD1↑, 1,   IDH2↓, 1,   Insulin↓, 5,   MCU↓, 1,   MFN2↓, 1,   MFN2↑, 1,   mitResp↓, 25,   mitResp↑, 4,   mitResp⇅, 1,   MKK7↓, 1,   Mortalin↓, 1,   mRET↑, 1,   mtDam?, 1,   mtDam↓, 3,   mtDam↑, 128,   OCR↓, 26,   OCR↑, 9,   mt-OCR↓, 1,   OXPHOS↓, 24,   OXPHOS↑, 18,   OXPHOS⇅, 1,   OXPHOS↝, 3,   OXPHOS∅, 1,   mt-OXPHOS↓, 4,   mt-OXPHOS↑, 2,   PDH↓, 6,   PDH↑, 7,   PDH↝, 1,   p‑PDH↓, 2,   p‑PDH↑, 1,   PGC-1α↑, 2,   PHB↑, 1,   PINK1↑, 6,   SDH↓, 4,   SDH↑, 1,   SIRT3↓, 3,   SIRT3↑, 8,   SSBP1↑, 1,   TrxR2↓, 1,   mt-TrxR2↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 7,   5LO↓, 10,   6PGD↓, 1,   ACC↓, 2,   ACC↑, 4,   p‑ACC↑, 1,   ACLY↓, 5,   p‑ACLY↓, 1,   ACSL4↑, 4,   ACSL4↝, 1,   ACSL4∅, 1,   adiP↑, 1,   ALAT↓, 12,   ALAT↑, 1,   ALAT↝, 1,   ALAT∅, 1,   ALDOA↓, 3,   ALDOB↑, 1,   AminoA↓, 1,   AMP↓, 1,   AMP↑, 3,   AMPK↓, 4,   AMPK↑, 70,   p‑AMPK↑, 10,   p‑AMT/GCST/T-protein↑, 1,   ANXA7↑, 2,   ATP↓, 112,   ATP↑, 4,   ATP↝, 1,   ATP∅, 1,   i-ATP↓, 1,   mt-ATP↓, 1,   ATP:AMP↓, 1,   BHB↑, 1,   CAIX/CA9↓, 5,   CAIX/CA9↑, 1,   CholSyn↓, 1,   citrate↓, 2,   CPT1A↓, 1,   CRM↑, 3,   DHCR24↑, 1,   DHODH↓, 2,   ECAR↓, 11,   ECAR↝, 1,   ECAR∅, 1,   ENO1↓, 4,   ENO3↑, 1,   FABP4↑, 1,   FAO↓, 2,   FASN↓, 14,   FASN↑, 1,   FBP1↑, 1,   FBPase↑, 1,   FDG↓, 2,   G6PD↓, 4,   G6PD∅, 1,   GAPDH↓, 7,   GDH↓, 1,   GLO-I↓, 3,   GLS↓, 2,   glucoNG↓, 2,   glucoNG↑, 1,   glucose↓, 6,   glucose↝, 1,   GlucoseCon↓, 45,   GlucoseCon↑, 4,   GlucoseCon∅, 2,   glut↓, 2,   GlutaM↓, 2,   GlutMet↓, 2,   GlutMet↑, 1,   glyC↓, 1,   Glycolysis↓, 129,   Glycolysis↑, 2,   Glycolysis↝, 1,   Glycolysis∅, 1,   GSK‐3β↓, 19,   GSK‐3β↑, 13,   GSK‐3β↝, 1,   p‑GSK‐3β↓, 13,   p‑GSK‐3β↑, 1,   H2S↑, 1,   HAGH/GLO2↓, 1,   Histones↑, 2,   ac‑Histones↑, 1,   HK1↓, 2,   HK2↓, 57,   HK2↑, 2,   HK2∅, 1,   HK3↑, 1,   HMG-CoA↓, 2,   HMGCS2↑, 1,   IDH1↓, 1,   IDO1↓, 1,   KeyT↑, 1,   lact/pyru↓, 1,   lactateProd↓, 50,   lactateProd↑, 6,   lactateProd∅, 2,   LDHA↓, 30,   LDHA↑, 1,   LDHA∅, 1,   LDL↓, 4,   lipidLev↓, 1,   lipoGen↓, 2,   MCT4↓, 4,   NAD↓, 6,   NAD↑, 2,   NAD↝, 1,   NADH:NAD↓, 1,   NADPH↓, 17,   NADPH↑, 8,   NADPH↝, 1,   PCK1↓, 2,   PCK1↑, 1,   PDHA1↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 24,   p‑PDK1 / PDPK1↓, 1,   PDK3↑, 1,   PDKs↓, 11,   PDKs↑, 1,   PFK↓, 9,   PFK1↓, 4,   PFK1↑, 1,   PFK2?, 1,   PFKP↓, 3,   PGK1↓, 1,   PGK2↑, 1,   PGM1↑, 1,   PGM3↑, 1,   PKLR↑, 1,   PKM2↓, 42,   PKM2↑, 2,   p‑PKM2↓, 1,   PLA2↓, 1,   polyA↓, 1,   PPP↓, 5,   PPP↑, 1,   Pyrim↓, 1,   Pyruv↓, 4,   Pyruv↑, 1,   R5P↝, 1,   RNR↓, 1,   p‑S6↓, 2,   SCD1↓, 2,   SIRT1↓, 18,   SIRT1↑, 21,   SIRT2↓, 2,   SIRT2↑, 1,   SLC1A5↓, 1,   SLC25A1↓, 1,   SREBP1/SREBF1↓, 2,   SREBP2↓, 2,   SSAT↑, 1,   TCA?, 1,   TCA↓, 11,   TCA↑, 3,   TCA↝, 1,   TS↓, 3,   TumCM/A↓, 1,   Warburg↓, 31,   Warburg↑, 1,   β-oxidation↓, 2,  

Cell Death(tgid=5) ⓘ

AIF↑, 42,   AIF↝, 1,   APAF1↑, 13,   Apoptosis?, 8,   Apoptosis↓, 26,   Apoptosis↑, 865,   Apoptosis↝, 1,   m-Apoptosis↑, 1,   mt-Apoptosis↑, 10,   ASC↓, 1,   ASC↑, 2,   ASK1↑, 5,   p‑ASK1↑, 1,   BAD↓, 4,   BAD↑, 30,   p‑BAD↓, 1,   Bak↓, 1,   Bak↑, 29,   BAX↓, 14,   BAX↑, 372,   BAX⇅, 2,   BAX↝, 1,   Bax:Bcl2↓, 1,   Bax:Bcl2↑, 81,   Bcl-2↓, 388,   Bcl-2↑, 9,   Bcl-2↝, 1,   Bcl-2∅, 1,   cl‑Bcl-2↑, 1,   Bcl-xL↓, 79,   Bcl-xL↑, 1,   Bcl-xL↝, 1,   BID↓, 2,   BID↑, 20,   p‑BID↓, 1,   cl‑BID↑, 3,   BIM↑, 20,   BNIP3?, 2,   BNIP3↑, 4,   BNIP3↝, 2,   BOK↑, 1,   Casp↓, 3,   Casp↑, 128,   Casp↝, 1,   cl‑Casp↑, 3,   proCasp↑, 1,   Casp1↓, 3,   Casp1↑, 3,   cl‑Casp1↑, 2,   Casp10↑, 3,   Casp10∅, 1,   Casp12?, 1,   Casp12↑, 10,   cl‑Casp12↑, 1,   cl‑Casp12↝, 1,   pro‑Casp12↓, 1,   Casp2↑, 3,   Casp3?, 3,   Casp3↓, 10,   Casp3↑, 464,   Casp3↝, 1,   Casp3∅, 1,   cl‑Casp3↓, 2,   cl‑Casp3↑, 109,   cl‑Casp3⇅, 1,   cl‑Casp3∅, 1,   proCasp3↓, 4,   proCasp3↑, 6,   pro‑Casp3↑, 1,   CASP4↑, 3,   Casp6↓, 1,   Casp6↑, 4,   Casp7↑, 53,   cl‑Casp7↑, 6,   Casp8↓, 3,   Casp8↑, 104,   Casp8∅, 3,   cl‑Casp8↑, 16,   proCasp8↑, 2,   Casp9?, 1,   Casp9↓, 3,   Casp9↑, 264,   Casp9∅, 1,   cl‑Casp9↓, 1,   cl‑Casp9↑, 45,   proCasp9↓, 1,   proCasp9↑, 2,   CellShr↑, 2,   cFLIP↓, 13,   Cupro↑, 3,   Cyt‑c↓, 5,   Cyt‑c↑, 296,   Cyt‑c↝, 4,   Cyt‑c?, 1,   cl‑Cyt‑c↑, 1,   mt-Cyt‑c↓, 1,   Diablo↑, 16,   DIDO1/DIO-1↑, 1,   DR5↓, 1,   DR5↑, 61,   DR5∅, 1,   Endon↑, 5,   FADD↑, 14,   FADD∅, 1,   Fap1↓, 2,   Fas?, 1,   Fas↓, 2,   Fas↑, 43,   FasL↑, 21,   Ferroptosis↓, 4,   Ferroptosis↑, 106,   GranB/GZMB↝, 1,   GRP58↓, 2,   GSDMD↑, 4,   cl‑GSDMD↑, 1,   GSDME↑, 2,   cl‑GSDME↑, 2,   GSDME-N↑, 2,   HEY1↓, 1,   IAP1↓, 19,   IAP2/BIRC3↓, 9,   IAP2/BIRC3↑, 1,   cl‑IAP2/BIRC3↑, 1,   ICAD↓, 2,   ICD↑, 7,   iNOS↓, 34,   iNOS↑, 3,   JWA↑, 1,   Mcl-1?, 1,   Mcl-1↓, 46,   Mcl-1↑, 2,   p‑Mcl-1↓, 1,   MDM2↓, 21,   MDM2↑, 1,   p‑MDM2↓, 2,   MLKL↑, 5,   p‑MLKL↓, 1,   MOMP↓, 1,   MOMP↑, 14,   NAIP↓, 1,   Necroptosis↑, 18,   necrosis↑, 20,   NOXA↑, 7,   oncosis↑, 2,   p38↓, 18,   p38↑, 54,   p‑p38↓, 4,   p‑p38↑, 17,   Paraptosis↑, 6,   PDCD4↑, 1,   Perforin↝, 1,   proApCas↑, 1,   PUMA↓, 2,   PUMA↑, 14,   PUMA⇅, 1,   PUMA↝, 1,   Pyro↑, 17,   RIP3↓, 1,   RIP3↑, 8,   p‑RIP3↑, 3,   survivin↓, 112,   TNFR 1↑, 3,   TRAIL↑, 14,   TRAIL⇅, 1,   TRAILR↑, 3,   TumCD?, 1,   TumCD↓, 4,   TumCD↑, 111,   TumCD∅, 2,   TUNEL↑, 1,   XIAP↓, 52,   XIAP↑, 2,   YAP/TEAD↓, 9,   YAP/TEAD↑, 2,   β-TRCP↑, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 328,   Akt↑, 16,   Akt↝, 2,   p‑Akt↓, 86,   p‑Akt↑, 2,   AKT1↓, 5,   Akt2↓, 2,   AMPKα↑, 7,   BCAP↓, 1,   BRAF↝, 1,   CaMKII ↓, 4,   CaMKII ↑, 1,   p‑CaMKII ↓, 1,   CIP2A↓, 3,   CK2↓, 9,   cMET↓, 6,   p‑cMET↑, 2,   CREB↓, 1,   cSrc↓, 4,   DDIT4↑, 1,   EF-1α↓, 1,   EGFR↓, 69,   EGFR↑, 2,   EGFR↝, 2,   p‑EGFR↓, 4,   ERK↓, 106,   ERK↑, 27,   ERK↝, 1,   p‑ERK↓, 27,   p‑ERK↑, 11,   p‑ERK⇅, 1,   p‑ERK↝, 1,   e-ERK↑, 1,   FGFR1↓, 4,   FGFR2↓, 1,   FOXD3↑, 2,   HCAR2↑, 3,   HER2/EBBR2↓, 22,   HGF/c-Met↓, 3,   Hippo↓, 1,   Hippo↑, 1,   Hippo↝, 1,   IGF-1R↓, 10,   IGF-1R↑, 1,   p‑IGF-1R↓, 1,   IGFR↓, 1,   IKKα↓, 8,   IKKα↑, 4,   p‑IKKα↓, 1,   IκB↓, 4,   IκB↑, 2,   p‑IκB↓, 2,   JAK↓, 13,   JAK↝, 1,   p‑JAK↓, 1,   JAK1?, 1,   JAK1↓, 12,   JAK1↑, 2,   p‑JAK1↓, 1,   JAK2↓, 27,   p‑JAK2↓, 4,   JAK3↓, 1,   JNK↓, 11,   JNK↑, 83,   JNK↝, 2,   p‑JNK↓, 5,   p‑JNK↑, 13,   LATS1↓, 1,   LIMK1↓, 1,   MAP2K1/MEK1↓, 2,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 72,   MAPK↑, 55,   MAPK↝, 5,   p‑MAPK↓, 4,   p‑MAPK↑, 8,   MARK4↓, 3,   MEK↓, 8,   p‑MEK↓, 2,   p‑MEK↑, 1,   MKK4↓, 1,   MKP1↓, 2,   MKP2↓, 2,   Mst1↑, 1,   mTOR↓, 187,   mTOR↑, 9,   mTOR⇅, 1,   mTOR↝, 2,   p‑mTOR↓, 27,   p‑mTOR↑, 1,   mTORC2↓, 5,   mTORC2↑, 1,   p42↑, 1,   p‑p42↓, 1,   p‑p42↑, 1,   p70S6↓, 5,   p70S6↑, 1,   p‑p70S6↓, 1,   p‑p70S6↑, 1,   P70S6K↓, 11,   P70S6K↑, 1,   p‑P70S6K↓, 3,   p85S6K↓, 1,   P90RSK↓, 2,   PDGFR-BB↓, 1,   PFKFB2↓, 1,   PHKG1↑, 1,   PI3K↓, 224,   PI3K↑, 11,   PI3K↝, 3,   p‑PI3K↓, 15,   p‑PI3K↑, 1,   PI3K/Akt↓, 7,   PI3K/Akt↑, 1,   PI3K/Akt⇅, 1,   PI3K/Akt↝, 1,   PI3k/Akt/mTOR↓, 3,   p‑PI3k/Akt/mTOR↓, 1,   PIAS-3↑, 1,   PIK3CA↓, 1,   PKA↓, 6,   PKCδ↓, 19,   PKCδ↑, 1,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↓, 5,   PTEN↑, 57,   PTEN↝, 2,   PTK2B / PYK2↓, 1,   PTP1B↓, 1,   Raf↓, 8,   e-Raf↓, 1,   c-Raf↓, 1,   RAS↓, 22,   RAS↑, 1,   RET↓, 1,   RIP1↓, 4,   RIP1↑, 5,   p‑RIP1↑, 1,   p‑S6K↓, 3,   SHP1↑, 2,   Sp1/3/4↓, 31,   Src↓, 5,   p‑Src↓, 2,   STAT↓, 9,   p‑STAT↓, 1,   STAT3↓, 167,   STAT3↑, 8,   STAT3⇅, 1,   STAT3↝, 1,   p‑STAT3↓, 35,   p‑STAT3↑, 3,   mt-STAT3↓, 1,   STAT5↓, 5,   STAT6↓, 3,   p‑STAT6↓, 1,   STK11/LKB1↑, 2,   p‑STK11/LKB1↑, 1,   THEM4/CTMP↑, 1,   TK1↓, 1,   TSC2↑, 3,   p‑TSC2↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

Ac-histone H3↑, 1,   ATF2↓, 3,   ATF3↓, 1,   ATF3↑, 4,   ATF4↓, 1,   ATF4↑, 31,   ATF4↝, 1,   p‑ATF4↝, 1,   ATFs↑, 1,   CBP↓, 1,   ChrMod↑, 2,   ChrMod↝, 1,   cJun↓, 13,   cJun↑, 7,   p‑cJun↑, 2,   cMyc↓, 85,   cMyc↑, 3,   p‑cMyc↑, 1,   CREBBP↓, 1,   DLEU1↓, 1,   DNMT1↓, 18,   DNMT1↑, 1,   DNMT3A↓, 5,   DNMT3B↓, 2,   DNMTs↓, 14,   DNMTs⇅, 1,   EZH2↓, 8,   FOXM1↓, 10,   FOXO↓, 1,   FOXO↑, 5,   FOXO1↓, 6,   FOXO1↑, 5,   FOXO3↓, 8,   FOXO3↑, 15,   FOXO3↝, 1,   p‑FOXO3↓, 2,   FOXO4↓, 2,   FOXO4↑, 3,   H3↓, 4,   H3↑, 2,   p‑H3↓, 1,   p‑H3↑, 1,   ac‑H3↓, 1,   ac‑H3↑, 3,   H3K9↓, 1,   H4↓, 1,   H4↑, 2,   ac‑H4↓, 1,   ac‑H4↑, 2,   HATs↓, 8,   HATs↑, 2,   HATs⇅, 1,   HDAC↓, 61,   HDAC⇅, 1,   HDAC1↓, 15,   HDAC10↑, 1,   HDAC2↓, 8,   HDAC3↓, 5,   HDAC4↓, 2,   HDAC6↓, 3,   HDAC8↓, 3,   HES1↓, 4,   HMTs↓, 4,   HOXB-AS1↓, 1,   JPT1/HN1↓, 1,   KISS1↑, 1,   KLF2↓, 1,   KLF5↓, 1,   LINC01116↓, 1,   miR-106b↓, 1,   miR-107↑, 1,   miR-10b-5p↓, 1,   miR-124-3p↓, 1,   miR-125b↓, 1,   miR-130a↓, 1,   miR-139-5p↑, 2,   miR-148a↑, 1,   miR-155↓, 3,   miR-182-5p↓, 1,   miR-19b↓, 1,   miR-200c↑, 1,   miR-203↑, 1,   miR-21↓, 14,   miR-21↑, 1,   miR-210↓, 1,   miR-218↑, 1,   miR-22↑, 2,   miR-221↓, 1,   miR-224↓, 1,   miR-25-5p↓, 1,   miR-27a-3p↓, 2,   miR-30a-5p↑, 1,   miR-339-5p↝, 1,   miR-340↓, 1,   miR-34a↓, 3,   miR-34a↑, 7,   miR-34b-5p↑, 1,   miR-384↑, 2,   miR-422a↑, 1,   miR-486↑, 1,   miR-590-3p↑, 1,   miR-592↑, 1,   MTA2↓, 2,   Myc↓, 10,   Myc↑, 1,   MYCN↓, 1,   n-MYC↓, 1,   NDRG1↑, 1,   NNMT↓, 1,   OCT4↓, 23,   other?, 3,   other↓, 16,   other↑, 33,   other⇅, 1,   other↝, 52,   other∅, 2,   OV6↓, 1,   PAX2↓, 1,   PCAF↓, 1,   PhotoS↑, 6,   RUNX2↓, 1,   Set9↑, 1,   SETBP1↓, 1,   Shc↓, 1,   sonoS↑, 4,   SOX2↓, 21,   SOX4↓, 4,   SOX4↑, 1,   SOX9?, 1,   SOX9↓, 3,   SUMO↓, 1,   SUV39H↓, 5,   TCF-4↓, 3,   TET3↑, 1,   TFE3↑, 2,   tumCV?, 3,   tumCV↓, 270,   tumCV↑, 5,   tumCV∅, 4,   USF1↑, 1,   UTF1↑, 1,   YMcells↓, 1,   ZBTB10↑, 2,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 7,   cl‑ATF6↑, 1,   CHOP/DDIT3↓, 2,   CHOP/DDIT3↑, 82,   CHOP/DDIT3↝, 1,   p‑CHOP/DDIT3↝, 1,   cl‑CHOP/DDIT3↑, 1,   COX17↝, 1,   CRT↑, 1,   i-CRT↓, 1,   CUL1↝, 1,   CUL5↝, 1,   EDEM↑, 1,   eIF2α↓, 4,   eIF2α↑, 18,   p‑eIF2α↓, 1,   p‑eIF2α↑, 12,   p‑eIF2α↝, 1,   ER Stress↓, 6,   ER Stress↑, 184,   ER Stress↝, 1,   Erlin1↑, 1,   ERStress↑, 2,   GRP78/BiP?, 1,   GRP78/BiP↓, 3,   GRP78/BiP↑, 45,   GRP78/BiP↝, 1,   GRP94↑, 2,   HSF1↓, 2,   HSP27↓, 8,   HSP27↑, 2,   HSP27↝, 1,   HSP70/HSPA5↓, 10,   HSP70/HSPA5↑, 17,   HSP70/HSPA5⇅, 1,   HSP70/HSPA5↝, 1,   HSP72↓, 1,   HSP90↓, 25,   HSP90↑, 3,   HSPs↓, 2,   HSPs↑, 3,   HTRA↓, 1,   IRE1↑, 9,   NQO2↑, 1,   PDI↑, 3,   PERK↓, 1,   PERK↑, 23,   p‑PERK↑, 3,   p‑PERK↝, 1,   Proteasome?, 1,   Proteasome↓, 3,   PSMB5↓, 1,   UPR↓, 1,   UPR↑, 31,   XBP-1↓, 2,   XBP-1↑, 5,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 4,   ATG5↑, 18,   ATG7↑, 6,   autoF↓, 1,   AVOs↑, 1,   Beclin-1/ATG6↓, 7,   Beclin-1/ATG6↑, 45,   p‑Beclin-1/ATG6↑, 1,   CTSB↓, 1,   CTSD↓, 1,   LAMP1?, 1,   LAMP2↑, 1,   LC3‑Ⅱ/LC3‑Ⅰ↓, 2,   LC3‑Ⅱ/LC3‑Ⅰ↑, 11,   LC3A↑, 3,   LC3B↑, 10,   LC3B-II↑, 9,   LC3I↑, 2,   LC3II↓, 2,   LC3II↑, 34,   LC3s↓, 1,   LC3s↑, 5,   LC3s↝, 1,   lysoMP↑, 2,   LysoPr↑, 1,   lysosome↝, 1,   MitoP↓, 1,   MitoP↑, 5,   p62↓, 26,   p62↑, 19,   PARK2↑, 6,   RUBCN↓, 1,   SESN2↑, 4,   TFEB↑, 1,   TumAuto↓, 8,   TumAuto↑, 177,   TumAuto⇅, 2,   TumAuto↝, 1,   ULK1/ATG1↑, 1,   p‑ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

APE1/APEX1↓, 1,   ATM?, 1,   ATM↑, 11,   p‑ATM↑, 3,   ATR↑, 2,   p‑ATR↑, 1,   BRCA1↓, 4,   BRCA1↑, 3,   p‑BRCA1↑, 1,   BRCA2↓, 2,   BRCA2↑, 1,   DFF45↓, 1,   DFF45↑, 3,   DNA-PK↑, 5,   DNAdam↓, 8,   DNAdam↑, 274,   mt-DNAdam↑, 2,   DNArepair↓, 11,   DNArepair↑, 3,   ERCC3↑, 1,   m-FAM72A↓, 1,   FEN1↓, 2,   G9a↓, 1,   HR↓, 2,   hTERT/TERT↓, 19,   Ku70/XRCC6↓, 1,   MGMT↓, 3,   p16↑, 8,   P53?, 2,   P53↓, 11,   P53↑, 268,   P53↝, 7,   P53∅, 1,   p‑P53↓, 2,   p‑P53↑, 14,   ac‑P53↑, 1,   p53 Wildtype∅, 1,   p73↑, 1,   PARP↓, 11,   PARP↑, 51,   PARP∅, 1,   p‑PARP↑, 3,   cl‑PARP↓, 5,   cl‑PARP↑, 197,   cl‑PARP↝, 1,   cl‑PARP∅, 2,   proPARP↓, 1,   PARP1↓, 1,   PARP1↑, 5,   cl‑PARP1↑, 7,   PCNA↓, 57,   POLD1↓, 1,   RAD51↓, 3,   RAD51↑, 1,   SIRT6↓, 2,   SIRT6↑, 1,   Telomerase↓, 26,   TOP1?, 1,   TOP1↓, 18,   TOP1↝, 1,   TOP1∅, 1,   TOP2↓, 10,   TOP2↑, 1,   TP53↓, 3,   TP53↑, 5,   TRF2↓, 2,   UHRF1↓, 2,   XRCC1↓, 2,   γH2AX↓, 1,   γH2AX↑, 29,   γH2AX↝, 1,   p‑γH2AX↑, 7,  

Cell Cycle & Senescence(tgid=11) ⓘ

ANAPC2↑, 1,   AURKB↑, 1,   CC(CDKs/cyclins)↓, 1,   CDK1↓, 39,   CDK1↑, 8,   CDK1↝, 1,   p‑CDK1↓, 2,   p‑CDK1↑, 1,   CDK2↓, 70,   CDK2↑, 6,   CDK4↓, 81,   CDK4↑, 5,   CDK4∅, 1,   p‑CDK4↓, 1,   CDK4/6↓, 1,   CDK6↓, 29,   CDK6↑, 7,   CDK6∅, 1,   CDK7↓, 1,   CDK8↓, 2,   CDKN1C/p57↓, 1,   CDKN1C/p57↑, 1,   CDKN2C/p18↑, 1,   cellSen↑, 2,   CHK1↓, 5,   CHK1↑, 4,   CHK1↝, 1,   p‑CHK1↑, 3,   Chk2↓, 4,   Chk2↑, 8,   p‑Chk2↑, 2,   ChrCon↑, 1,   Cyc↓, 5,   Cyc↝, 1,   cycA1/CCNA1↓, 22,   cycA1/CCNA1↑, 2,   CycB/CCNB1↓, 53,   CycB/CCNB1↑, 10,   CycB/CCNB1↝, 1,   cycD1/CCND1↓, 165,   cycD1/CCND1↑, 4,   cycD1/CCND1↝, 1,   cycD1/CCND1∅, 1,   p‑cycD1/CCND1↓, 1,   CycD3↓, 5,   CycD3↑, 1,   cycE/CCNE↓, 40,   cycE/CCNE↑, 3,   cycE/CCNE↝, 1,   cycE1↓, 3,   cycF↑, 1,   E2Fs↓, 5,   E2Fs↑, 1,   GADD45A↓, 1,   GADD45A↑, 6,   Ki-67↓, 61,   Ki-67↑, 1,   MAD↓, 1,   mitA↓, 1,   mitA↑, 4,   p19↑, 1,   P21?, 2,   P21↓, 10,   P21↑, 166,   P21↝, 1,   p27/CDKN1B↓, 5,   p27/CDKN1B↑, 59,   pRB↓, 2,   pRB↑, 1,   p‑pRB↓, 5,   RB1↑, 3,   p‑RB1↓, 8,   RRM2↓, 1,   Securin↓, 2,   TAp63α↑, 1,   TumCCA?, 5,   TumCCA↓, 14,   TumCCA↑, 631,   TumCCA∅, 1,   WEE1↑, 4,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 2,   p‑4E-BP1↓, 3,   ALDH↓, 17,   ALDH1A1↓, 3,   ALDH1A3↓, 1,   Axin2↑, 1,   BMI1↓, 3,   BMP7/OP1↓, 2,   BMPs↑, 3,   CD133↓, 17,   CD133↑, 1,   CD24↓, 4,   CD34↓, 2,   cFos↓, 12,   cFos↑, 2,   cMYB↓, 2,   CSCs?, 1,   CSCs↓, 106,   CSCs↑, 3,   CSCsMark↓, 2,   Diff↓, 1,   Diff↑, 13,   EIF4E↓, 3,   EP4/PTGER4↑, 1,   FGF↓, 4,   FOSL1↑, 1,   Gli↓, 1,   Gli1↓, 11,   HH↓, 8,   HMGCR↓, 2,   IGF-1?, 1,   IGF-1↓, 19,   IGF-2↓, 1,   IGF-2↑, 1,   IGFBP1↑, 2,   IGFBP3↓, 1,   IGFBP3↑, 5,   IGFBP7↑, 1,   JAG1↓, 1,   Jun↓, 2,   p‑Jun↓, 1,   p‑Jun↑, 1,   Ki-67↓, 61,   Ki-67↑, 1,   Let-7↓, 1,   Let-7↑, 3,   LRP6↓, 1,   mTORC1↓, 16,   p‑mTORC1↓, 1,   Nanog↓, 23,   Nestin↓, 4,   NICD↓, 1,   NOTCH↓, 29,   NOTCH↑, 2,   NOTCH1↓, 23,   NOTCH1↑, 4,   NOTCH2↑, 1,   NOTCH3↓, 4,   p300↓, 2,   Piezo1↑, 2,   PTCH1↓, 3,   SCF↓, 1,   Shh↓, 11,   Smo↓, 6,   STAT1↓, 2,   STAT1↑, 1,   p‑STAT1↓, 1,   TAZ↓, 1,   TumCG?, 3,   TumCG↓, 330,   TumCG↑, 8,   TumCP?, 2,   TumCP↓, 482,   TumCP↑, 13,   TumCP⇅, 1,   tyrosinase↓, 2,   Wnt?, 1,   Wnt↓, 75,   Wnt↑, 2,   Wnt↝, 1,   Wnt/(β-catenin)↓, 11,   Wnt/(β-catenin)↑, 1,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AEG1↑, 1,   Alix/AIP‑1↓, 3,   annexin II↓, 1,   AntiAg?, 1,   AntiAg↓, 1,   AntiAg↑, 3,   AP-1↓, 22,   AP-1↑, 2,   AP-1↝, 1,   APC↑, 2,   ASAP2↓, 1,   ATPase↓, 2,   ATPase↑, 1,   AXL↓, 3,   BACH1↓, 1,   BACH1↑, 1,   CA↓, 2,   Ca+2↓, 12,   Ca+2↑, 127,   Ca+2↝, 11,   i-Ca+2?, 1,   i-Ca+2↑, 8,   CAFs/TAFs↓, 3,   Cal1↑, 2,   cal2↓, 1,   cal2↑, 4,   Cal9↑, 1,   CCN2/CTGF↓, 1,   CD11b↑, 1,   Cdc42↓, 3,   Cdc42↑, 1,   Chl↑, 1,   i-Chl↑, 1,   Cofilin↓, 2,   COL1↓, 3,   COL3A1↓, 1,   CTNNB1↓, 1,   DLC1↑, 1,   E-cadherin↓, 14,   E-cadherin↑, 86,   EMT?, 1,   EMT↓, 161,   EMT↑, 4,   EMT↝, 1,   EpCAM↓, 4,   F-actin↓, 3,   FAK↓, 30,   FAK↑, 1,   p‑FAK↓, 7,   fascin↓, 1,   Fibronectin↓, 7,   FOSB↑, 1,   Furin↓, 3,   GIT1↓, 1,   GLI2↓, 3,   ITGA5↓, 1,   ITGB1↓, 3,   ITGB1↑, 1,   ITGB3↓, 2,   ITGB4↓, 1,   ITGB6↓, 1,   KRAS↓, 3,   LAMs↓, 3,   LEF1↓, 2,   LIMK2↓, 1,   LRP1↓, 1,   LRP1↑, 1,   MALAT1↓, 6,   MET↓, 4,   MET↑, 2,   p‑MET↓, 2,   MMP-10↓, 3,   MMP1↓, 11,   MMP13↓, 7,   MMP15↓, 1,   MMP16↓, 2,   MMP2?, 1,   MMP2↓, 182,   MMP2↑, 1,   MMP2↝, 1,   proMMP2↓, 1,   MMP3↓, 11,   MMP7↓, 19,   MMP7∅, 1,   MMP9?, 1,   MMP9↓, 205,   MMP9↑, 5,   MMP9:TIMP1↓, 1,   MMPs↓, 72,   MTA1↓, 1,   MUC1↑, 1,   MUC4↓, 4,   N-cadherin↓, 57,   N-cadherin↑, 1,   NCAM↑, 1,   NFAT↑, 1,   p‑p44↓, 1,   p‑p44↑, 1,   PAK1↓, 4,   PAK1↑, 1,   pax↓, 1,   p‑pax↓, 1,   PDGF↓, 8,   Rac1↓, 4,   RECK↑, 1,   Rho↓, 8,   Rho↑, 1,   Rho↝, 1,   ROCK1↓, 7,   ROCK1↑, 2,   Sharpin↓, 1,   Slug?, 1,   Slug↓, 19,   Smad1↓, 2,   Smad1↑, 3,   SMAD2↓, 3,   p‑SMAD2↓, 1,   SMAD3↓, 4,   SMAD3↑, 1,   p‑SMAD3↓, 1,   SMAD4↓, 3,   SMAD4↑, 1,   p‑SMAD4↓, 1,   Snail?, 2,   Snail↓, 47,   STAC2↓, 1,   T-cadherin↓, 1,   T-cadherin↑, 1,   talin↓, 1,   TET1?, 1,   TET1↓, 1,   TET1↑, 10,   TGF-β↓, 32,   TGF-β↑, 4,   TGF-β1↓, 2,   THBS1↓, 1,   TIMP1↓, 4,   TIMP1↑, 19,   TIMP2↓, 6,   TIMP2↑, 20,   TIMP3↑, 1,   TRIB3↑, 3,   TSC1↑, 2,   TSP-1↑, 4,   TumCA↓, 6,   TumCA↑, 1,   TumCI?, 1,   TumCI↓, 189,   TumCI↑, 2,   TumCMig↓, 222,   TumCMig↑, 3,   TumCMig⇅, 1,   TumMeta↓, 163,   TumMeta↑, 11,   TumPF↓, 3,   Twist↓, 34,   TXNIP↑, 4,   Tyro3↓, 1,   uPA↓, 34,   uPA↝, 1,   uPAR↓, 4,   Vim?, 1,   Vim↓, 70,   Vim↑, 1,   Zeb1↓, 23,   Zeb1↑, 1,   ZEB2↓, 4,   α-SMA↓, 2,   α-SMA↑, 1,   α-tubulin↓, 2,   α-tubulin↑, 1,   β-catenin/ZEB1↓, 90,   β-catenin/ZEB1↑, 3,   β-catenin/ZEB1↝, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 222,   angioG↑, 7,   CD31/PECAM-1↓, 4,   ECM/TCF↓, 2,   EGR1↓, 1,   EGR1↑, 1,   EGR4↓, 1,   Endoglin↑, 3,   eNOS↓, 3,   eNOS↑, 1,   HIF-1↓, 15,   HIF-1↑, 2,   Hif1a↓, 151,   Hif1a↑, 10,   Hif1a↝, 2,   Hypoxia↓, 5,   Hypoxia↑, 1,   LOX1↓, 3,   NO↓, 12,   NO↑, 17,   NO↝, 1,   PHDs↓, 1,   REL↑, 1,   VCAM-1↓, 6,   VEGF↓, 206,   VEGF↑, 4,   VEGF↝, 1,   VEGFR1↓, 5,   VEGFR2/KDR/Flk1↓, 26,  

Barriers & Transport(tgid=15) ⓘ

AQPs↓, 1,   BBB↓, 1,   BBB↑, 17,   BBB↝, 1,   BBB∅, 2,   CellMemb↓, 1,   CellMemb↑, 9,   CLDN1↓, 6,   CLDN1↑, 1,   CLDN2↓, 2,   CTR1↑, 2,   CTR1↝, 1,   CX43/GJA1↓, 1,   EPR↓, 1,   EPR↑, 24,   EPR↝, 1,   GLUT1↓, 40,   GLUT1↑, 4,   GLUT2↓, 3,   GLUT3↓, 2,   GLUT3↑, 2,   GLUT4↓, 7,   IBI↑, 1,   KCNH2/hERG↓, 1,   LAT↓, 1,   MMP?, 2,   MMP↓, 548,   MMP↑, 15,   MMP↝, 4,   MMP∅, 3,   MPT↓, 1,   MPT↑, 24,   NHE1↓, 5,   OCLN↑, 1,   SLC12A5↓, 1,   SMCT1∅, 1,   sonoP↑, 1,   SVCT-2↝, 1,   SVCT-2∅, 2,   TJ↑, 1,   TRPM7↓, 3,   TRPM7↑, 1,   TRPV1↓, 1,   TRPV1↑, 11,   TRPV1↝, 1,   TRPV2↑, 1,   VGCC↓, 1,   VGSC↓, 1,   ZO-1↓, 1,   ZO-1↑, 4,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1,   CCR7↓, 1,   CD14↑, 1,   CD155↓, 1,   CD25+↑, 1,   CD4+↓, 1,   CD4+↑, 8,   CD44↓, 26,   CD47↓, 2,   CD59↑, 1,   CD8+↑, 13,   cDC2↓, 5,   cGAS–STING↑, 2,   COX1↓, 5,   COX1↑, 1,   COX2/PTGS2↓, 166,   COX2/PTGS2↑, 7,   COX2/PTGS2↝, 1,   CXCc↓, 1,   CXCL1↓, 1,   CXCL12↓, 3,   CXCL16↓, 1,   CXCL9↓, 1,   CXCR2↓, 2,   CXCR2↑, 1,   CXCR4↓, 21,   CXCR4↑, 1,   DCells↑, 3,   DR4↑, 15,   DR4∅, 2,   DR6↑, 1,   Eos↑, 1,   FOXP3↓, 2,   FOXP3↑, 3,   Gal-3↓, 2,   Gal1↑, 1,   HCAR1↓, 1,   HCAR2↑, 3,   HLA-I/II↑, 1,   HMGB1↓, 6,   i-HMGB1↓, 1,   ICAM-1↓, 14,   IFN-γ↓, 10,   IFN-γ↑, 4,   Igs↓, 1,   Igs↑, 2,   IL1↓, 11,   IL1↑, 4,   IL10↓, 9,   IL10↑, 3,   IL12↓, 3,   IL12↑, 3,   IL17↓, 1,   IL18↓, 1,   IL18↑, 1,   IL1β↓, 39,   IL1β↑, 6,   IL2↓, 7,   IL2↑, 6,   IL33↑, 1,   IL4↓, 5,   IL4↑, 2,   IL6↓, 94,   IL6↑, 3,   IL6↝, 1,   IL8↓, 20,   IL8↑, 4,   Imm↑, 46,   Imm↝, 5,   INF-γ↝, 1,   Inflam↓, 90,   Inflam↑, 1,   Inflam↝, 1,   IRAK1↓, 2,   LRIG1↑, 1,   M1↑, 1,   pol-M1↑, 2,   M2 MC↓, 5,   M2 MC↑, 1,   pol-M2 MC↓, 1,   Macrophages↓, 1,   MCP1/CCL2↓, 10,   MCT1↓, 5,   MIP-1β↑, 1,   MIP2↓, 2,   NAF1↓, 3,   Neut↓, 1,   Neut↑, 2,   NF-kB?, 1,   NF-kB↓, 342,   NF-kB↑, 19,   NF-kB↝, 2,   p‑NF-kB↓, 4,   p‑NF-kB↑, 3,   NK cell↑, 19,   NK cell⇅, 1,   NLRP3↓, 13,   NLRP3↑, 7,   NOD1↓, 1,   p50↓, 3,   p65↓, 18,   p65↑, 1,   p‑p65↓, 5,   ac‑p65↓, 1,   PD-1↓, 4,   PD-1↝, 1,   PD-L1↓, 20,   PD-L1↑, 4,   PGD2↓, 1,   PGE1↓, 1,   PGE2↓, 36,   PSA↓, 19,   PSA↝, 1,   RAGE↓, 2,   RAGE↑, 1,   RANTES?, 1,   Resistin↓, 1,   SOCS-3↓, 1,   SOCS-3↑, 1,   SOCS1↑, 1,   T-Cell↑, 8,   T-Cell↝, 1,   TCF↓, 3,   TCF↑, 1,   TCF↝, 1,   Th1 response↑, 3,   Th17↑, 1,   TIGIT↓, 1,   TLR1↑, 1,   TLR2↓, 2,   TLR4↓, 11,   TLR4↝, 1,   TNF-α↓, 75,   TNF-α↑, 15,   TNF-α↝, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 5,   TRADD↑, 1,   Treg lymp↓, 3,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   GFAP↓, 2,   GGT/CD224↑, 1,   pH↓, 3,   pH↑, 2,   pH↝, 3,   i-pH↓, 2,   i-pH↑, 1,   TAMS↝, 1,   Temp∅, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

GABA↑, 1,   MAOA↓, 1,   PTN↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↑, 1,   Aβ↓, 1,   BACE/β-secretase↓, 1,   PRNP↑, 1,   PSEN1/PS1↓, 1,   XO↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   AhR↓, 2,   AhR↓, 2,   AKR1C3/17β-HSD5/PGF Synthase↓, 1,   AR↓, 36,   AR↑, 1,   AR↝, 1,   COMT↓, 1,   CYP19↓, 1,   ER-α36↓, 8,   ER(estro)↓, 3,   ERα/ESR1↓, 3,   ERβ/ESR2↑, 1,   Estro↝, 1,   FGF21↓, 1,   Irisin↓, 1,   Leptin↓, 1,   PPARα↓, 1,   PPARα↑, 3,   cl‑PPARα↓, 1,   PPARγ↓, 6,   PPARγ↑, 11,   PPARγ↝, 1,   RANKL↓, 2,   SRC3↓, 1,   SXR↓, 1,   SXR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABC↓, 2,   ABCG2↓, 3,   AKR1B10↓, 1,   BioAv↓, 98,   BioAv↑, 108,   BioAv↝, 31,   BioEnh?, 1,   BioEnh↑, 10,   CBR1↓, 1,   chemoR↓, 2,   ChemoSen?, 2,   ChemoSen↓, 6,   ChemoSen↑, 465,   ChemoSen⇅, 2,   ChemoSen↝, 1,   ChemoSen∅, 4,   CompStab?, 1,   CompStab↓, 3,   CompStab↑, 8,   CompStab↝, 2,   CYP1A1↓, 8,   CYP1A1↑, 4,   CYP1A2↓, 2,   CYP1A2↑, 1,   CYP1B1↓, 1,   CYP1B1↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 5,   DDS↑, 5,   Dose?, 13,   Dose↓, 10,   Dose↑, 32,   Dose⇅, 4,   Dose↝, 178,   Dose∅, 44,   DrugR↓, 1,   eff?, 2,   eff↓, 368,   eff↑, 362,   eff⇅, 1,   eff↝, 52,   eff∅, 5,   GSTA1↓, 3,   GSTA1↑, 2,   GSTP1/GSTπ↓, 3,   GSTZ1↝, 1,   Half-Life?, 1,   Half-Life↓, 26,   Half-Life↑, 7,   Half-Life↝, 27,   Half-Life∅, 2,   MDR1↓, 17,   MRP1/ABCC1↓, 5,   MRP1/ABCC1↑, 1,   MRP1/ABCC1↝, 1,   NAT↓, 1,   P-gp/ABCB1↓, 45,   P-gp/ABCB1↑, 2,   P-gp/ABCB1⇅, 1,   P450↓, 9,   P450↝, 1,   RadioS?, 1,   RadioS↓, 3,   RadioS↑, 174,   RadioS↝, 2,   selectivity?, 5,   selectivity↓, 6,   selectivity↑, 398,   selectivity↝, 3,   selectivity∅, 4,   Synergy?, 1,   Synergy↑, 294,   Synergy↝, 1,   TET2↓, 1,   TET2↑, 4,  

Clinical Biomarkers(tgid=22) ⓘ

AFP?, 1,   AFP↓, 4,   ALAT↓, 12,   ALAT↑, 1,   ALAT↝, 1,   ALAT∅, 1,   ALP↓, 4,   ALP↝, 1,   AR↓, 36,   AR↑, 1,   AR↝, 1,   AST↓, 7,   AST↑, 1,   AST↝, 1,   AST∅, 1,   BG↓, 6,   BloodF↑, 3,   BMD↑, 3,   BP↓, 2,   BRAF↝, 1,   BRCA1↓, 4,   BRCA1↑, 3,   p‑BRCA1↑, 1,   BUN↓, 2,   CA19-9↓, 1,   CEA↓, 3,   creat↓, 3,   CRP↓, 6,   E6↓, 5,   E7↓, 5,   EGFR↓, 69,   EGFR↑, 2,   EGFR↝, 2,   p‑EGFR↓, 4,   ERα/ESR1↓, 3,   EZH2↓, 8,   Ferritin↓, 8,   Ferritin↑, 1,   FOXM1↓, 10,   HER2/EBBR2↓, 22,   hTERT/TERT↓, 19,   IL6↓, 94,   IL6↑, 3,   IL6↝, 1,   IRes↓, 1,   KeyT↑, 1,   KRAS↓, 3,   LDH?, 1,   LDH↓, 27,   LDH↑, 13,   LDH↝, 3,   e-LDH↑, 1,   i-LDH↓, 1,   Maspin↑, 1,   Myc↓, 10,   Myc↑, 1,   NLR↓, 1,   NOS2↓, 2,   NOS2↑, 1,   NSE↓, 1,   PC↑, 1,   PD-L1↓, 20,   PD-L1↑, 4,   Polyps↓, 1,   PSA↓, 19,   PSA↝, 1,   PSADT↑, 1,   RAGE↓, 2,   RAGE↑, 1,   RBC↑, 1,   RBM3↑, 1,   TG/TAG↓, 1,   TP53↓, 3,   TP53↑, 5,   TRIB3↑, 3,   Tumccf↓, 4,   Tumccf↑, 1,   Urea↓, 1,   WBC↑, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 2,   AntiCan↓, 4,   AntiCan↑, 189,   AntiCan∅, 1,   antiCG↓, 1,   antiD↑, 1,   antiNeop↑, 9,   AntiTum↓, 2,   AntiTum↑, 84,   AntiTum∅, 1,   Appetite↑, 2,   BowelM↑, 2,   breath↑, 1,   cachexia↓, 4,   cardioP↑, 25,   CardioT↓, 2,   CardioT↑, 1,   CardioT↝, 1,   chemoP↓, 1,   chemoP↑, 96,   chemoPv↑, 61,   ChemoSideEff↓, 20,   cognitive?, 1,   cognitive↑, 5,   fatigue↓, 1,   fatigue∅, 1,   hepatoP↓, 3,   hepatoP↑, 29,   K17↓, 1,   LC↑, 1,   motorD↑, 1,   Mucositis↓, 2,   neuroP↓, 1,   neuroP↑, 28,   NKG2D↑, 1,   NP/CIPN↓, 3,   NP/CIPN↑, 1,   Obesity↓, 2,   OS↓, 2,   OS↑, 66,   OS⇅, 1,   OS∅, 2,   Pain↓, 8,   PFS↓, 1,   PFS↑, 1,   PFS∅, 1,   Pin1↓, 2,   QoL↑, 19,   QoL∅, 1,   radioP↑, 35,   Remission↑, 6,   RenoP↑, 26,   Risk↓, 52,   Risk↑, 2,   Sleep↑, 3,   Strength↑, 2,   toxicity?, 1,   toxicity↓, 59,   toxicity↑, 12,   toxicity⇅, 1,   toxicity↝, 31,   toxicity∅, 11,   TumNum↓, 1,   TumVol↓, 73,   TumVol↑, 1,   TumW↓, 30,   Weight↓, 1,   Weight↑, 7,   Weight∅, 3,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiFungal↑, 1,   AntiP↑, 3,   AntiViral↑, 1,   Bacteria↓, 9,   GutMicro↑, 15,   GutMicro↝, 3,   Sepsis↓, 5,  

Ingredients & Constituents(tgid=25) ⓘ

Api↑, 1,   Ingr?, 5,   Ingr↝, 15,  
Total Targets: 1909

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↓, 6,   antiOx?, 2,   antiOx↓, 26,   antiOx↑, 494,   mt-antiOx↑, 1,   ARE↓, 1,   ARE↑, 12,   ARE↝, 1,   Bil↓, 2,   Bil↑, 2,   Catalase↓, 7,   Catalase↑, 230,   Catalase↝, 1,   Copper↓, 2,   DPPH↓, 1,   DUOX1↓, 1,   Fenton↓, 7,   GCLC↑, 6,   GCLC↝, 1,   GCLM↑, 5,   GCLM↝, 1,   GPx↓, 6,   GPx↑, 167,   GPx1↑, 9,   GPx4↓, 2,   GPx4↑, 13,   GPx4∅, 1,   GSH↓, 12,   GSH↑, 261,   GSH⇅, 1,   GSH/GSSG↑, 4,   GSR↓, 3,   GSR↑, 32,   GSS↑, 2,   GSSG↓, 4,   GSSG∅, 1,   GSTs↓, 4,   GSTs↑, 42,   H2O2↓, 20,   H2O2↑, 1,   H2O2∅, 1,   HDL↓, 1,   HDL↑, 15,   HDL∅, 1,   HNE↓, 3,   HNE↑, 1,   HO-1?, 1,   HO-1↓, 7,   HO-1↑, 193,   HO-1⇅, 1,   HO-1↝, 1,   HO-1∅, 1,   HO-2↓, 1,   hyperG↓, 2,   hyperG↝, 1,   Iron↓, 12,   Iron↑, 2,   Iron↝, 2,   i-Iron↓, 3,   i-Iron↑, 1,   Keap1↓, 18,   Keap1↑, 2,   Keap1↝, 2,   ox-Keap1↑, 1,   lipid-P?, 1,   lipid-P↓, 202,   lipid-P↑, 7,   mt-lipid-P↓, 1,   MDA?, 1,   MDA↓, 213,   MDA↑, 8,   MPO↓, 31,   MPO↑, 2,   NADH↓, 1,   NFE2L2↓, 1,   NOX↓, 5,   NOX2↓, 2,   NOX4↓, 11,   NQO1↑, 50,   NQO1↝, 2,   Nrf1↓, 1,   Nrf1↑, 6,   NRF2?, 1,   NRF2↓, 12,   NRF2↑, 329,   NRF2⇅, 1,   NRF2↝, 2,   NRF2∅, 2,   p‑NRF2↑, 2,   Prx↓, 1,   Prx↑, 6,   Prx4∅, 1,   RNS↓, 14,   ROMO1↑, 1,   ROS?, 10,   ROS↓, 1144,   ROS↑, 61,   ROS⇅, 14,   ROS↝, 3,   ROS∅, 27,   i-ROS↑, 1,   mt-ROS?, 1,   mt-ROS↓, 12,   mt-ROS↑, 4,   RPM↑, 1,   RPM↝, 1,   selenoP↑, 16,   SOD?, 1,   SOD↓, 10,   SOD↑, 323,   SOD↝, 1,   mt-SOD↑, 1,   SOD1↓, 2,   SOD1↑, 17,   SOD2↑, 19,   TAC↑, 42,   TAC∅, 1,   TBARS↓, 11,   TBARS↑, 1,   Thiols↑, 5,   TOS↓, 2,   Trx↓, 1,   Trx↑, 7,   Trx1↑, 6,   TrxR↓, 1,   TrxR↑, 4,   TrxR1↑, 3,   UCPs↑, 2,   UCPs↝, 1,   uricA↓, 6,   VitC↑, 8,   VitE↓, 1,   VitE↑, 5,   xCT/SLC7A11↓, 1,   xCT/SLC7A11↑, 4,  

Metal & Cofactor Biology(tgid=2) ⓘ

Ferritin↓, 1,   Ferritin↑, 2,   FPN↑, 1,   FTH1↓, 1,   FTH1↑, 2,   FTL↓, 1,   IronCh↓, 1,   IronCh↑, 42,   IronCh↝, 1,   Mets↝, 1,   NCOA4↝, 1,   TfR1/CD71↓, 4,   TfR1/CD71↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↓, 1,   compI↓, 2,   compI↑, 4,   compII↑, 2,   compIII↓, 1,   compIII↑, 3,   compIV↑, 3,   compV↑, 1,   DRP1/DNM1L↓, 5,   DRP1/DNM1L↑, 2,   p‑DRP1/DNM1L↝, 1,   EGF↓, 1,   ETC↓, 4,   ETC↑, 4,   ETC↝, 2,   FIS1↓, 5,   FIS1↑, 1,   HSP60/HSPD1↓, 1,   Insulin↓, 4,   Insulin↑, 5,   MFN1↓, 1,   MFN1↑, 1,   MFN1↝, 1,   MFN2↓, 2,   MFN2↑, 5,   MFN2↝, 1,   mitResp↓, 1,   mitResp↑, 11,   mtDam↓, 30,   mtDam↑, 1,   NGB↑, 1,   OCR↓, 2,   OCR↑, 8,   mt-OCR↑, 1,   OPA1↓, 2,   OPA1↑, 2,   OXPHOS↓, 3,   OXPHOS↑, 5,   PDH↑, 1,   PGC-1α↓, 1,   PGC-1α↑, 22,   PGC-1α↝, 2,   PINK1↓, 1,   PINK1↑, 3,   SIRT3↑, 14,   TFAM↑, 4,   UCP1↓, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 7,   15-LOX/ALOX15↓, 1,   5LO↓, 18,   ACADS/SCAD↑, 1,   ACC↓, 2,   ACC↑, 2,   mt-ACC⇅, 1,   Acetyl-CoA↓, 1,   Acetyl-CoA↑, 4,   ACSL4↓, 3,   ACSL4∅, 1,   adiP↑, 1,   ALAT?, 1,   ALAT↓, 70,   ALAT↑, 1,   ALDOA↑, 1,   AMP↓, 1,   AMPK↓, 2,   AMPK↑, 58,   AMPK⇅, 1,   p‑AMPK↑, 4,   ATP↓, 5,   ATP↑, 49,   ATP∅, 1,   mt-ATP↑, 1,   BMAL1↑, 1,   Buty↑, 1,   cAMP↑, 7,   CPT1A↑, 2,   CRM↑, 5,   cytoP450↓, 1,   DGAT1↓, 1,   DHA↑, 1,   ECAR↓, 3,   ECAR↑, 1,   FABP4↓, 1,   FAM↑, 1,   FAO↓, 1,   FAO↑, 6,   FASN↓, 7,   FFA/NEFA↓, 3,   G6PD↑, 1,   glucose↓, 18,   glucose↑, 1,   glucose↝, 6,   GlucoseCon↓, 2,   GlucoseCon↑, 17,   GlutMet↑, 1,   glyC↓, 1,   Glycolysis↓, 3,   Glycolysis↑, 6,   Glycolysis↝, 2,   GPI↑, 1,   GSK‐3β↓, 36,   GSK‐3β↑, 7,   p‑GSK‐3β↓, 1,   p‑GSK‐3β↑, 5,   H2S↑, 4,   HK2↓, 2,   HK2↑, 6,   HMG-CoA↓, 3,   IDH1↑, 1,   KeyT↝, 1,   lactateProd↓, 2,   LDHA↓, 2,   LDHA↑, 2,   LDHB↑, 1,   LDL↓, 43,   lipidLev↓, 6,   lipoGen↓, 2,   NAD↓, 1,   NAD↑, 6,   NADH:NAD↑, 1,   NADPH↓, 18,   NADPH↑, 13,   NADPH∅, 1,   PDK1 / PDPK1↓, 1,   PDKs↓, 1,   PDKs↑, 1,   PFK↓, 1,   PFK↑, 1,   PFK2↓, 1,   PFKL↑, 3,   PFKM↑, 2,   PFKP↑, 1,   PGC1A↑, 1,   PGM1?, 1,   PKM1↑, 2,   PKM2↓, 6,   PKM2↑, 4,   PLA2↓, 2,   PONs↑, 1,   PPP↓, 2,   SCD1↓, 1,   SCFAs↑, 2,   SIRT1↓, 1,   SIRT1↑, 62,   SIRT1↝, 1,   SIRT2↑, 1,   SREBF2⇅, 1,   SREBP1/SREBF1↓, 4,   SREBP1/SREBF1↑, 1,   TCA↑, 1,  

Cell Death(tgid=5) ⓘ

AIF↓, 4,   AIF↑, 1,   APAF1↓, 1,   Apoptosis↓, 110,   Apoptosis↑, 1,   Apoptosis∅, 1,   ASC?, 1,   ASC↓, 4,   ASK1↓, 1,   BAD↓, 3,   BAX↓, 45,   BAX↑, 7,   Bax:Bcl2↓, 7,   Bax:Bcl2↑, 3,   Bcl-2↓, 9,   Bcl-2↑, 37,   Bcl-2↝, 1,   Bcl-2∅, 1,   Bcl-xL↓, 1,   Bcl-xL↑, 2,   BNIP3↓, 1,   Casp↓, 4,   Casp1↓, 9,   cl‑Casp1↓, 1,   proCasp1↓, 1,   Casp12↓, 4,   Casp3?, 1,   Casp3↓, 81,   Casp3↑, 8,   Casp3∅, 1,   cl‑Casp3↓, 13,   cl‑Casp3↑, 1,   proCasp3↑, 1,   Casp6↓, 1,   Casp7↓, 1,   Casp8↓, 4,   Casp8↑, 1,   cl‑Casp8↓, 1,   cl‑Casp8↑, 2,   Casp9↓, 25,   Casp9↑, 4,   cl‑Casp9↓, 2,   cl‑Casp9↑, 1,   Cyt‑c↓, 16,   Cyt‑c↑, 4,   Cyt‑c∅, 3,   Fas↓, 5,   Fas↑, 2,   Ferroptosis↓, 20,   Ferroptosis↑, 2,   GranB/GZMB↓, 1,   GSDMD↓, 2,   HEY1↑, 1,   iNOS↓, 100,   iNOS↑, 2,   necrosis↓, 3,   p38↓, 15,   p38↑, 3,   p‑p38↓, 11,   Pyro?, 1,   Pyro↓, 4,   survivin↓, 1,   TUNEL↓, 1,   YAP/TEAD↑, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt?, 1,   Akt↓, 20,   Akt↑, 45,   Akt↝, 2,   p‑Akt↓, 7,   p‑Akt↑, 11,   e-Akt↑, 1,   AMPKα↑, 2,   CaMKII ↓, 1,   CREB↓, 1,   CREB↑, 14,   p‑CREB↑, 8,   EGFR↓, 2,   ERK↓, 14,   ERK↑, 14,   p‑ERK↓, 7,   p‑ERK↑, 7,   e-ERK↑, 1,   HCAR2↑, 1,   HGF/c-Met↑, 2,   Hippo↑, 1,   IGF-1R↓, 1,   IKKα↓, 2,   IKKα↑, 1,   p‑IKKα↓, 2,   IκB?, 1,   IκB↓, 1,   p‑IκB↓, 1,   JAK↓, 3,   p‑JAK1↓, 1,   JAK2↓, 3,   JAK2↑, 5,   p‑JAK2↓, 2,   JNK↓, 21,   JNK↑, 3,   p‑JNK↓, 10,   p‑JNK↑, 1,   LPAR1/EDG2↑, 1,   MAPK?, 1,   MAPK↓, 49,   MAPK↑, 6,   MAPK↝, 3,   p‑MAPK?, 1,   p‑MAPK↓, 2,   p‑MEK↓, 1,   p‑MKK4↑, 1,   Mst1↓, 2,   mTOR↓, 18,   mTOR↑, 12,   p‑mTOR↓, 6,   p‑mTOR↑, 1,   p‑p70S6↓, 1,   P70S6K↓, 1,   PDGFR-BB↓, 2,   PDGFR-BB↑, 1,   PDGFRB↓, 1,   PFKFB2↓, 1,   PI3K↓, 16,   PI3K↑, 33,   PI3K↝, 1,   p‑PI3K↑, 1,   PKA↑, 3,   PKCδ?, 1,   PKCδ↓, 3,   PKCδ↑, 6,   p‑PKCδ↑, 1,   PP2A↑, 4,   PTEN↓, 4,   PTEN↑, 3,   p‑PTEN↑, 1,   Raf↓, 1,   RAS↓, 2,   RIP1↓, 1,   STAT↓, 4,   STAT3?, 1,   STAT3↓, 11,   STAT3↑, 7,   STAT3↝, 1,   p‑STAT3↓, 2,   p‑STAT3↑, 1,   STAT5↓, 1,   STK11/LKB1↑, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 12,   ATF2↑, 1,   ATF4↓, 5,   ATF4↑, 1,   cJun↓, 3,   p‑cJun↓, 2,   cMyc↓, 1,   p‑cMyc↑, 1,   DNMT1↓, 3,   DNMT3A↓, 1,   DNMTs↓, 1,   FOXO↑, 3,   FOXO1↑, 1,   FOXO1↝, 1,   FOXO3?, 1,   FOXO3↑, 7,   HATs↓, 1,   HDAC?, 1,   HDAC↓, 7,   HDAC↑, 2,   HDAC2↓, 1,   HDAC3↓, 1,   HOTAIR↑, 1,   miR-155↓, 1,   miR-23a-3p↓, 1,   miR-34a↓, 1,   OCT4↓, 1,   other?, 4,   other↓, 28,   other↑, 45,   other↝, 51,   other∅, 1,   RUNX2↑, 1,   SOX2↑, 1,   tumCV↓, 3,   tumCV↑, 1,   tumCV∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↓, 2,   CHOP/DDIT3↓, 16,   CHOP/DDIT3↑, 2,   eIF2α↓, 1,   p‑eIF2α↓, 2,   cl‑eIF2α↑, 1,   ER Stress↓, 32,   ER Stress↑, 2,   GRP78/BiP↓, 16,   GRP78/BiP↑, 4,   GRP94↑, 1,   HSF1↑, 1,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 14,   HSP70/HSPA5↝, 1,   HSP90↓, 2,   HSP90↑, 1,   HSPs↑, 3,   HSPs↝, 1,   IRE1↓, 3,   NQO2↑, 1,   PDI↓, 1,   PERK↓, 3,   p‑PERK↓, 1,   p‑PERK↑, 1,   UPR↓, 4,   UPR↑, 2,   XBP-1↓, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG3↓, 1,   ATG5↓, 1,   ATG5↑, 1,   ATG7↓, 1,   autophagy↓, 1,   autophagy↑, 1,   Beclin-1/ATG6↓, 6,   Beclin-1/ATG6↑, 9,   LC3‑Ⅱ/LC3‑Ⅰ↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 2,   LC3A↑, 1,   LC3B↓, 1,   LC3B↑, 2,   LC3II↓, 2,   LC3II↑, 5,   LC3s↓, 1,   MitoP↑, 6,   p62↓, 5,   p62↑, 5,   PARK2↑, 5,  

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↓, 1,   ATM↑, 1,   ATR↑, 1,   p‑BRCA1↑, 1,   DNAdam↓, 45,   DNAdam↑, 2,   DNAdam∅, 1,   DNArepair↑, 2,   p16↓, 1,   P53↓, 9,   P53↑, 5,   P53↝, 1,   PARP↓, 2,   p‑PARP↓, 1,   cl‑PARP↓, 2,   cl‑PARP↑, 2,   PARP1↓, 1,   cl‑PARP1↓, 1,   PCNA↓, 4,   SIRT6↑, 3,   Telomerase↓, 2,   TOP1↓, 1,   γH2AX↓, 1,   p‑γH2AX↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 1,   CDK2↓, 2,   CDK4↓, 1,   CDK5↓, 4,   cellSen↝, 1,   cycA1/CCNA1↓, 1,   CycB/CCNB1↓, 1,   cycD1/CCND1↓, 2,   cycE/CCNE↓, 1,   cycE/CCNE↑, 1,   E2Fs↑, 1,   GADD34↓, 1,   Ki-67↓, 3,   Ki-67↑, 2,   P21↓, 6,   P21↑, 3,   RB1↓, 1,   TumCCA↑, 6,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

p‑4E-BP1↓, 1,   BMP2↑, 1,   CD34↑, 1,   CEBPA↓, 1,   cFos↓, 1,   cFos↑, 1,   CHIP↑, 1,   Choline↑, 1,   Diff↑, 4,   Diff↝, 1,   FGF↑, 3,   HH↓, 1,   IGF-1↓, 3,   IGF-1↑, 3,   IGFBP1↑, 1,   IGFBP3↑, 1,   Ki-67↓, 3,   Ki-67↑, 2,   Nestin↑, 1,   neuroG↑, 7,   NOTCH↓, 1,   NOTCH↑, 1,   NOTCH1↑, 1,   p300↓, 1,   p‑STAT1↓, 1,   TumCG↓, 3,   TumCP↓, 4,   tyrosinase↓, 2,   Wnt↓, 1,   Wnt↑, 3,   Wnt/(β-catenin)↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↓, 3,   AntiAg↑, 42,   AP-1↓, 13,   AP-1↑, 1,   ARG1/2↑, 1,   BACH1↓, 1,   Ca+2?, 2,   Ca+2↓, 39,   Ca+2↑, 9,   Ca+2↝, 6,   Ca+2∅, 1,   i-Ca+2↓, 2,   cal2↓, 2,   Cartilage↑, 8,   p‑Cofilin↓, 1,   COL1↓, 5,   COL1↑, 2,   COL3A1↓, 2,   E-cadherin↑, 3,   EMT↓, 4,   EMT↑, 1,   FAK↑, 1,   Fibronectin↓, 1,   Fibrosis↓, 1,   heparanase↑, 1,   LRP1↑, 1,   MMP-10↓, 1,   MMP1↓, 3,   MMP13↓, 6,   MMP2↓, 9,   MMP2↑, 3,   MMP3↓, 5,   MMP9↓, 18,   MMP9↑, 2,   MMPs↓, 5,   MMPs↑, 1,   MUC1↑, 2,   N-cadherin↑, 1,   Na+↑, 1,   NFAT↓, 1,   PAI-1/SERPINE1↓, 1,   PDGF↓, 1,   PDGF↑, 1,   p‑Rac1↓, 1,   Rho↓, 3,   ROCK1↓, 3,   Sema3A/PlexinA1↑, 1,   p‑Smad1↑, 1,   SMAD2↓, 1,   p‑SMAD2↓, 2,   SMAD3↓, 2,   p‑SMAD3↓, 1,   p‑SMAD3↑, 1,   p‑SMAD5↑, 1,   Smad7↑, 1,   Snail↑, 1,   p‑T-cadherin↓, 2,   TG2/TGase↓, 1,   TGF-β↓, 15,   TGF-β↑, 7,   TGF-β1↓, 5,   TGF-β1↑, 3,   TIMP1↓, 2,   TIMP1↑, 1,   TIMP2↑, 1,   TregCell↑, 1,   TumCI↓, 2,   TumCMig↓, 1,   TumCMig↑, 1,   TumMeta↓, 1,   Twist↑, 1,   TXNIP↓, 7,   TXNIP↑, 2,   Tyro3↓, 1,   uPA↑, 1,   Vim↓, 6,   Vim↑, 1,   α-SMA↓, 12,   α-SMA↑, 1,   α-SMA↝, 1,   α-tubulin↓, 1,   β-catenin/ZEB1↑, 5,   β-catenin/ZEB1↝, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 4,   angioG↑, 13,   CD31/PECAM-1↑, 2,   E-sel↓, 3,   Endoglin↑, 1,   eNOS↓, 1,   eNOS↑, 5,   p‑eNOS↑, 2,   HIF-1↓, 2,   Hif1a↓, 9,   Hif1a↑, 5,   Hif1a↝, 1,   Hif1a∅, 1,   LOX1↓, 2,   NO?, 1,   NO↓, 75,   NO↑, 8,   TXA2↓, 1,   VCAM-1↓, 15,   VEGF↓, 10,   VEGF↑, 13,  

Barriers & Transport(tgid=15) ⓘ

BBB?, 1,   BBB↓, 6,   BBB↑, 101,   BBB↝, 4,   BBB∅, 3,   CellMemb↑, 1,   CLDN1↓, 2,   CLDN1↑, 1,   CLDN5↑, 1,   CX43/GJA1↑, 1,   GastroP↑, 11,   GLUT1↑, 3,   GLUT2↑, 2,   GLUT3↑, 3,   GLUT4↑, 7,   H+/K+-ATPase↓, 1,   IBI↑, 11,   memfluid↑, 2,   MMP↓, 14,   MMP↑, 68,   MMP⇅, 1,   MMP↝, 2,   MMP∅, 4,   MPT↑, 1,   MUC5AC↓, 1,   Na+↑, 1,   NHE3↑, 1,   OATPs↓, 1,   OCLN↓, 2,   OCLN↑, 1,   THBD↑, 1,   TJ↓, 1,   TJ↑, 4,   TRPA1↑, 1,   TRPC1↓, 1,   TRPC1↑, 1,   TRPM7↓, 3,   TRPM7⇅, 1,   TRPV1↑, 6,   TRPV3↑, 1,   VGCC↝, 1,   VGSC↓, 1,   ZO-1↓, 2,   ZO-1↑, 5,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

AIF1/Iba-1↓, 1,   AIM2↓, 1,   BALF-Infl↓, 1,   BALF-Lym↓, 1,   CB2 / CNR2↑, 2,   CCL11↓, 1,   CD19↑, 1,   CD25+↑, 1,   CD4+↑, 5,   CD40↓, 1,   CD8+↑, 1,   COX1↓, 10,   COX2/PTGS2?, 1,   COX2/PTGS2↓, 158,   COX2/PTGS2↑, 2,   COX2/PTGS2∅, 1,   CXCc↓, 1,   CXCL12↑, 1,   CXCL15↓, 1,   CXCR2↑, 1,   CXCR4↓, 2,   DCells↑, 1,   Eos↓, 2,   FOXP3↑, 1,   GM-CSF↓, 1,   GM-CSF↑, 1,   HCAR2↑, 1,   HMGB1↓, 8,   ICAM-1↓, 14,   IFN-γ↓, 15,   IFN-γ↑, 3,   IgE↓, 1,   IL1↓, 11,   IL1↑, 1,   IL10↓, 20,   IL10↑, 25,   IL12↓, 9,   IL13↓, 2,   IL17↓, 15,   IL17↑, 1,   IL18↓, 8,   IL1α↓, 1,   IL1β↓, 160,   IL1β↑, 2,   IL2↓, 13,   IL2↑, 3,   IL22↓, 2,   IL23↓, 4,   IL33↓, 2,   IL4↓, 11,   IL4↑, 8,   IL5↓, 4,   IL5↑, 1,   IL6?, 2,   IL6↓, 185,   IL6↑, 5,   IL8?, 1,   IL8↓, 28,   IL8↑, 1,   Imm↓, 1,   Imm↑, 28,   Imm⇅, 2,   Imm↝, 2,   INF-γ↓, 3,   INF-γ↑, 1,   Inflam?, 4,   Inflam↓, 619,   Inflam↑, 8,   Inflam∅, 1,   IP-10/CXCL-10↓, 2,   IP-10/CXCL-10↑, 1,   IRF3↓, 2,   LPS↓, 2,   LTA/TNF-β↓, 1,   LTA/TNF-β↑, 1,   M1↓, 1,   M2 MC↑, 1,   pol-M2 MC↑, 1,   MCP1/CCL2↓, 21,   MCP1/CCL2↑, 2,   MCT1↓, 1,   MIP2↓, 3,   mPGES-1↓, 1,   MyD88↓, 7,   NeuroI↓, 14,   Neut↓, 2,   Neut↑, 1,   NF-kB?, 1,   NF-kB↓, 254,   NF-kB↑, 4,   p‑NF-kB↓, 6,   NK cell↑, 4,   NLRP3↓, 67,   NLRP3↑, 4,   NOD1↓, 1,   p65↓, 5,   p‑p65↓, 1,   PAF↓, 2,   PAR-2↓, 1,   PGE1↓, 1,   PGE2↓, 46,   PGE2↑, 3,   RAGE↓, 7,   RANTES↓, 4,   SOCS-3↓, 1,   Th1 response↓, 1,   Th2↑, 2,   TLR1↓, 3,   TLR2↓, 5,   TLR3↓, 1,   TLR4↓, 36,   TLR4↑, 1,   TNF-α?, 1,   TNF-α↓, 254,   TNF-α↑, 3,   TRAF1↓, 1,   TRAF6↓, 1,   Treg lymp↝, 1,   TREM-1↓, 1,   TRIF↓, 2,   VitD↑, 1,   β-HEX↓, 1,  

Cellular Microenvironment(tgid=17) ⓘ

GFAP↓, 5,   GGT/CD224↓, 1,   pH↑, 1,   pH↝, 2,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 3,   5HT↑, 14,   Ach?, 1,   Ach↑, 28,   AChE↓, 115,   AChE↑, 3,   AChE↝, 2,   AChE∅, 1,   ADAM10↑, 7,   ADAM10↝, 1,   BChE↓, 25,   BDNF↓, 3,   BDNF↑, 84,   BDNF⇅, 1,   BDNF∅, 1,   BrainVol↑, 2,   CARTPT↑, 1,   ChAT↑, 17,   ChE↓, 1,   DA↑, 1,   EndoR↑, 1,   GABA↓, 3,   GABA↑, 7,   GABA↝, 1,   MAOA↓, 16,   MAOA↑, 1,   MAOA↝, 1,   MAOB↓, 7,   monoA↓, 1,   monoA↑, 2,   NGF↑, 11,   PSD95↑, 7,   RELN↑, 1,   SNAP25↑, 3,   TPH1↓, 1,   TrkB↓, 1,   TrkB↑, 9,   β-Endo↑, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 11,   APOE4↓, 1,   APP↓, 19,   cl‑APP↓, 1,   cl‑APP↑, 1,   Aβ?, 1,   Aβ↓, 187,   Aβ42↓, 11,   BACE/β-secretase↓, 50,   BACE/β-secretase↝, 1,   IDE↑, 1,   PSEN1/PS1↓, 1,   PSEN1/PS1↑, 1,   tau↓, 40,   p‑tau↓, 52,   XO↓, 5,   XO↝, 1,   β-Amyloid↓, 5,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 2,   ACE/ACE1↑, 1,   ACE2↓, 1,   AHR↓, 1,   AhR↑, 2,   AKR1C3/17β-HSD5/PGF Synthase↑, 1,   BNP↓, 1,   cortisol↓, 1,   CYP19↓, 1,   END↑, 1,   ER(estro)↓, 1,   ER(estro)↑, 2,   ERβ/ESR2↑, 1,   Estro↓, 1,   FGF21↑, 1,   GLP-1R↑, 1,   GR↓, 1,   GR↑, 2,   NR1H4↑, 1,   PPARα↑, 10,   PPARα↝, 1,   PPARγ↓, 2,   PPARγ↑, 24,   p‑PPARγ↓, 1,   PR↝, 1,   RAAS↓, 1,   testos↑, 1,   testos?, 1,   TSHR↓, 1,   VDR↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

AKR1B1/ALR2↑, 1,   AKR1B10↝, 1,   BioAv?, 1,   BioAv↓, 125,   BioAv↑, 163,   BioAv⇅, 3,   BioAv↝, 75,   BioAv∅, 2,   BioEnh↑, 9,   ChemoSen↑, 5,   CompStab↑, 4,   CompStab↝, 4,   CYP1A1↑, 1,   CYP1A2↑, 1,   CYP2D6↓, 1,   CYP2E1↓, 6,   CYP3A2↓, 2,   CYP3A4↓, 1,   Dose?, 9,   Dose↓, 3,   Dose↑, 9,   Dose⇅, 3,   Dose↝, 153,   Dose∅, 4,   eff↓, 12,   eff↑, 103,   eff↝, 10,   GSTA1↓, 2,   GSTA1↑, 4,   Half-Life↓, 17,   Half-Life↑, 10,   Half-Life↝, 38,   Half-Life∅, 3,   P-gp/ABCB1↓, 5,   P450↓, 4,   P450↑, 2,   P450↝, 1,   selectivity↑, 6,   Synergy↑, 50,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT?, 1,   ALAT↓, 70,   ALAT↑, 1,   ALB↑, 3,   ALP↓, 16,   anemia↓, 1,   AST↓, 76,   AST↑, 1,   BG↓, 8,   Bil↓, 2,   Bil↑, 2,   BloodF↑, 11,   BMD↑, 7,   BP↓, 31,   BP↝, 2,   BP∅, 1,   p‑BRCA1↑, 1,   BUN?, 1,   BUN↓, 8,   Calcium↝, 1,   CEA↓, 2,   CK/CK-MB↓, 1,   creat↓, 22,   CRP↓, 21,   EGFR↓, 2,   Ferritin↓, 1,   Ferritin↑, 2,   HbA1c↓, 1,   Hcy/homoC↓, 1,   HemoG↑, 1,   HOMA↓, 1,   hs-CRP↓, 2,   IL6?, 2,   IL6↓, 185,   IL6↑, 5,   IRes↓, 2,   IRes↑, 1,   IRes↝, 1,   KeyT↝, 1,   LDH↓, 28,   LDH↑, 3,   NLR↓, 1,   NOS2↓, 5,   RAGE↓, 7,   RBC↑, 1,   rHR↓, 1,   SpO2↑, 1,   TC↓, 6,   TG/TAG↓, 10,   TMAO↓, 1,   TMAO↑, 2,   Urea↓, 6,   VitD↑, 1,   VLDL↓, 1,  

Functional Outcomes(tgid=23) ⓘ

Airway↓, 1,   AirwayM↓, 1,   Analgesic↑, 3,   AntiAge↑, 32,   antiAll?, 1,   antiAll↑, 39,   AntiArt↑, 17,   AntiCan↓, 3,   AntiCan↑, 62,   antiCG↑, 3,   antiD↓, 1,   AntiDiabetic↓, 1,   AntiDiabetic↑, 75,   AntiMyl↑, 2,   antiNeop↑, 1,   antiPs↑, 5,   AntiTum↓, 2,   AntiTum↑, 14,   ANXi↓, 1,   Bone Healing↑, 1,   cardioP?, 3,   cardioP↓, 2,   cardioP↑, 192,   cardioP⇅, 1,   cardioP∅, 1,   CardioT↓, 4,   chemoP↑, 37,   chemoPv↑, 14,   cognitive↓, 5,   cognitive↑, 232,   cognitive↝, 1,   cognitive∅, 1,   cough?, 1,   cytoP↑, 1,   diuretic↑, 6,   fatigue↓, 2,   hepatoP↓, 7,   hepatoP↑, 182,   Learn↑, 20,   memory?, 1,   memory↓, 2,   memory↑, 210,   memory∅, 2,   Mood?, 1,   Mood↑, 7,   motorD↓, 2,   motorD↑, 35,   Mucositis↓, 2,   neuroP?, 2,   neuroP↓, 3,   neuroP↑, 437,   NP/CIPN↓, 3,   Obesity↓, 30,   OS↓, 1,   OS↑, 22,   Pain↓, 17,   PDE4↓, 1,   QoL↑, 4,   radioP↑, 32,   RenoP↓, 1,   RenoP↑, 70,   Risk↓, 16,   Sleep↑, 8,   SoreThr?, 1,   Strength↑, 7,   Stress↓, 4,   Stroke↓, 37,   Stroke↝, 1,   Tinn↓, 1,   toxicity?, 4,   toxicity↓, 155,   toxicity↑, 16,   toxicity⇅, 1,   toxicity↝, 35,   toxicity∅, 37,   Weight↓, 8,   Weight↑, 1,   Weight∅, 1,   Wound Healing↓, 2,   Wound Healing↑, 19,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 32,   AntiFungal↓, 2,   AntiFungal↑, 14,   AntiP↓, 1,   AntiP↑, 7,   AntiViral↑, 29,   Bacteria↓, 70,   Diar↓, 4,   GutMicro↑, 74,   Inf↓, 3,   Sepsis↓, 20,  

Ingredients & Constituents(tgid=25) ⓘ

CA↑, 1,   Catechins↑, 1,   FA↑, 1,   GA↑, 1,   Ingr?, 4,   Ingr↑, 2,   Ingr↝, 24,   Phen↑, 1,   Poly↑, 1,   QC↑, 1,  
Total Targets: 1158

Scientific Paper Hit Count for: ROS, Reactive Oxygen Species
125 Silver-NanoParticles
99 Curcumin
96 Magnetic Fields
96 Quercetin
75 Thymoquinone
60 Radiotherapy/Radiation
58 Resveratrol
57 Vitamin C (Ascorbic Acid)
57 Sulforaphane (mainly Broccoli)
55 Shikonin
51 Lycopene
50 Berberine
47 Hydrogen Gas
46 Luteolin
45 EGCG (Epigallocatechin Gallate)
43 Baicalein
42 Alpha-Lipoic-Acid
40 Selenite (Sodium)
40 Ashwagandha(Withaferin A)
40 Piperlongumine
39 Selenium NanoParticles
38 Artemisinin
37 Betulinic acid
35 Cisplatin
34 doxorubicin
34 Rosmarinic acid
34 Fisetin
33 Melatonin
33 Capsaicin
32 Silymarin (Milk Thistle) silibinin
31 Phenethyl isothiocyanate
31 Magnetic Field Rotating
29 Chemotherapy
29 Apigenin (mainly Parsley)
29 Propolis -bee glue
29 Honokiol
28 Copper and Cu NanoParticles
26 Allicin (mainly Garlic)
26 Emodin
26 Gambogic Acid
23 Chlorogenic acid
23 Chrysin
23 Juglone
23 Kaempferol
22 Licochalcone A
22 Vitamin K2
21 chitosan
20 Coenzyme Q10
19 isoquercitrin
19 isoorientin
18 Boron
18 Ferulic acid
18 Morin
17 salinomycin
17 Ivermectin
17 Parthenolide
16 Photodynamic Therapy
16 Urolithin
15 Benzyl isothiocyanate
15 Caffeic acid
15 chaetocin
15 Crocetin
15 Ellagic acid
15 Eugenol
15 Isoliquiritigenin
15 Phenylbutyrate
14 5-fluorouracil
14 Auranofin
14 Boswellia (frankincense)
14 Carnosic acid
14 Carvacrol
14 Selenium
13 Dichloroacetate
13 Dandelion Root
13 Gallic acid
13 Isovitexin
13 Magnolol
13 Matrine
13 Moringa oleifera
13 Pterostilbene
12 Graviola
12 HydroxyTyrosol
12 Isobavachalcone
12 Methylene blue
12 VitK3,menadione
11 Astaxanthin
11 Cinnamon
11 Ursolic acid
11 Cynaropicrin
11 Hyperthermia
11 Linalool
11 Piperine
10 SonoDynamic Therapy UltraSound
10 Beta-Caryophyllene
10 Bacopa monnieri
10 α-Bisabolol / Chamomile oil
10 Mung Bean Sprouts
10 diet FMD Fasting Mimicking Diet
10 Diindolylmethane
10 Ginkgo biloba
10 Hyperoside
10 Plumbagin
10 Mushroom Lion’s Mane, Hericium erinaceus
10 Nimbolide
9 Andrographis
9 D-limonene
9 borneol
9 NTP, Non-Thermal Plasma,Cold Atmospheric Plasma
9 Centella asiatica / Gotu kola → asiaticoside
9 Hydroxycinnamic-acid
9 Diclofenac
9 L-Theanine
9 Marjoram (Origanum majorana)
8 3-bromopyruvate
8 Rutin
8 Allyl isothiocyanate
8 Metformin
8 Isothiocyanates
8 Disulfiram
8 Electrical Pulses
8 Sulfasalazine
8 Vitexin
8 Magnesium
8 Propyl gallate
8 Phycocyanin
7 EMF
7 Gold NanoParticles
7 Gemcitabine (Gemzar)
7 Docetaxel
7 immunotherapy
7 Berbamine
7 brusatol
7 Carnosine
7 Celastrol
7 methylseleninic acid
7 Chlorella (Chlorella vulgaris)
7 diet Methionine-Restricted Diet
7 eicosapentaenoic acid
7 Formononetin
7 Garcinol
7 Ginkgetin
6 2-DeoxyGlucose
6 Phyllanthus emblica/Emblica officinalis/Amla / Indian Gooseberry
6 Anethole/trans-Anethole
6 Biochanin A
6 Butyrate
6 Chlorophyllin
6 Chocolate
6 Citric Acid
6 Carvone
6 Cynara scolymus/Globe Artichoke/Artichoke Extract
6 Lemongrass Extract/Citral
6 Aflavin-3,3′-digallate
6 Fenbendazole
6 Fucoidan
6 HydroxyCitric Acid
6 Isorhamnetin
6 Lutein
6 Methyl Jasmonate
6 Methylsulfonylmethane
5 1,8-Cineole
5 Brucea javanica
5 Bromelain
5 erastin
5 buckwheat sprouts
5 Thymol-Thymus vulgaris
5 Cichoric acid / Chicoric acid
5 Vitamin E
5 Spermidine
5 Huperzine A/Huperzia serrata
5 Date Fruit Extract
5 Docosahexaenoic Acid
5 Evodiamine
5 Flaxseed/Linseed
5 Lemon Balm/Melissa officinalis
5 Gossypol/AT-101
5 Inositol
5 Methylglyoxal
5 nicotinamide adenine dinucleotide
4 chemodynamic therapy
4 Zinc
4 Paclitaxel/Taxol
4 Cucurbitacin
4 Indole-3-carbinol
4 diet Short Term Fasting
4 Ginkgo biloba-EGb 761
4 SDG/lignans
4 Geraniol
4 Ginkgolide B
4 Ginseng
4 γ-linolenic acid (Borage Oil)
4 Hibiscus sabdariffa
4 lambertianic acid
4 Licorice
4 Lactoferrin/Talactoferrin
4 Myricetin
4 Mangiferin
4 Naringin
4 Patchouli Oil (Pogostemon cablin)
4 Taurine
3 5-Aminolevulinic acid
3 Anthocyanins
3 Glucose
3 Aromatherapy
3 temozolomide
3 Black phosphorus
3 Caffeic Acid Phenethyl Ester (CAPE)
3 Catechins
3 Choline
3 methotrexate
3 Dihydrocaffeic Acid
3 Spirulina(Arthrospira/Limnospira)
3 Oxygen, Hyperbaric
3 ferumoxytol
3 flavonoids
3 Shilajit/Fulvic Acid
3 Ginger/6-Shogaol/Gingerol
3 Grapeseed extract
3 Orlistat
3 phytic acid, Inositol hexakisphosphate
3 Modified Citrus Pectin
3 MCT oil
3 Moringin
3 Oleuropein
3 α-Santalol/Sandalwood oil
3 Shankhpushpi
3 Terpinen-4-ol / Tea Tree Oil
3 Turmerones
3 Vitamin B1/Thiamine
2 5-Hydroxytryptophan
2 Astragalus
2 DTS(dibenzyl trisulphide) from Anamu
2 Fennel Oil/Foeniculum vulgare
2 Ascorbyl Palmitate
2 Atorvastatin
2 Aloe anthraquinones
2 beta-glucans
2 Baicalin
2 Lapatinib
2 xanthohumol
2 Cannabidiol
2 beta-carotene(VitA)
2 Bufalin/Huachansu
2 Bruteridin(bergamot juice)
2 Bullatacin
2 Cat’s Claw
2 Celecoxib
2 Citicoline, CDP-Choline
2 Carica papaya leaf extract
2 Calorie Restriction Mimetics
2 Galantamine
2 CUSP9
2 Folic Acid, Vit B9
2 Galloflavin
2 Salvia officinalis
2 Germanium Organic/Ge-132 / propagermanium (organogermanium)
2 iodine
2 isoflavones
2 Potassium
2 mebendazole
2 Vitamin B3,Niacin
2 Niclosamide (Niclocide)
2 Pachymic acid
2 Sanguinarine
2 Psoralidin
2 Radio Frequency
2 Rauwolfia serpentina/Indian Snakeroot
2 Sesamin
2 Sesame seeds and Oil
2 Iron
2 Salvia miltiorrhiza
2 triptolide
2 Vitamin D3
1 cetuximab
1 Annona atemoya Leaf Extract
1 Annona atemoya Seed Extract
1 Açaí, Euterpe oleracea
1 Anzaroot, Astragalus fasciculifolius Bioss
1 entinostat
1 Camptothecin
1 Resiquimod
1 Ajoene (compound of Garlic)
1 Acetyl-l-carnitine
1 alpha Linolenic acid
1 Angelica archangelica / Garden Angelica
1 Anti-oxidants
1 Sorafenib (brand name Nexavar)
1 tamoxifen
1 almonertinib
1 epirubicin
1 Ras-selective lethal 3
1 Beetroot
1 Black Rice, Oryza sativa
1 Black Seed Oil/Nigella sativa
1 Lecithin
1 Camu camu
1 Chyawanprash
1 Cranberry
1 Aspirin
1 Rivastigmine
1 Cyclopamine
1 Cysteamine
1 Dichloroacetophenone(2,2-)
1 Deguelin
1 diet Fermented Foods
1 diet Ketogenic
1 diet Plant based
1 Echinacea
1 Cannabichromene
1 Exercise
1 Flaxseed Oil
1 olaparib/LYNPARZA
1 hydroxychloroquine
1 verapamil
1 Ginkgolic acids
1 Genistein (soy isoflavone)
1 Germanium inorganic
1 hydrogen sulfide
1 Helleborus niger extracts – Christmas Rose
1 Rapamycin
1 Inoscavin A
1 Butein
1 Scopoletin
1 Lactobacillus
1 Lapachol
1 Geldanamycin
1 MBE, Maqui berry
1 irinotecan
1 magnetic nanoparticles
1 Mistletoe/Viscum album Extracts
1 Mushroom Maitake
1 Myrrh
1 N-Acetyl-Cysteine
1 None
1 No Product/Mechanism Only
1 Oleocanthal
1 Oregano
1 sericin
1 Purple Corn / Purple Maize
1 topotecan
1 Polyphenols
1 benzo(a)pyrene
1 Rhein
1 Perilla
1 Oxaliplatin
1 Scoulerine
1 polyethylene glycol
1 Lignans
1 acetaminophen
1 Silicic Acid
1 Squalene
1 Osimertinib
1 Adagrasib
1 Glutathione
1 statins
1 Safflower yellow
1 Terminalia bellirica
1 Triphala
1 Vanillic Acid
1 Vitamin A, Retinoic Acid
1 Vitamin B12
1 Vitamin B2,Riboflavin
1 Vitamin B5,Pantothenic Acid
1 Transarterial Chemoembolization
1 glucose deprivation
1 probiotics
1 Walnut
1 Zinc Oxide
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:275  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page